CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | gold atom |
|
Accession: | CHEBI:29287
|
browse the term
|
Definition: | A copper group element atom that has formula Au. |
Synonyms: | related_synonym: | 79Au; Au; Formula=Au; Gold; InChI=1S/Au; InChIKey=PCHJSUWPFVWCPO-UHFFFAOYSA-N; SMILES=[Au]; aurum; or; oro |
| xref: | CAS:7440-57-5 |
| xref_mesh: | MESH:D006046 |
| xref: | WebElements:Au |
|
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of AASS mRNA Gold analog results in decreased expression of AASS mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression |
ISO |
Gold analog results in increased expression of ABCB1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABCB4 mRNA Gold analog results in decreased expression of ABCB4 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABCC1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression |
ISO |
Gold analog results in increased expression of ABCC2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABL1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
decreases expression |
ISO |
Gold analog results in decreased expression of ACAA1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
decreases expression |
ISO |
Gold analog results in decreased expression of ACACA mRNA |
CTD |
PMID:36057382 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acad11 |
acyl-CoA dehydrogenase family, member 11 |
decreases expression |
ISO |
Gold analog results in decreased expression of ACAD11 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:104,681,346...104,746,559
Ensembl chr 8:104,681,396...104,746,560
|
|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
decreases expression |
ISO |
Gold analog results in decreased expression of ACADM mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
|
|
G |
Acads |
acyl-CoA dehydrogenase short chain |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ACADS mRNA |
CTD |
PMID:28433809 |
|
NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898
|
|
G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ACADVL mRNA |
CTD |
PMID:28433809 |
|
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
|
|
G |
Aco1 |
aconitase 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of ACO1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
|
|
G |
Aco2 |
aconitase 2 |
decreases expression multiple interactions |
ISO |
Gold analog results in decreased expression of ACO2 protein [Polyethyleneimine binds to Gold] which results in increased expression of ACO2 mRNA |
CTD |
PMID:24780912 PMID:28433809 |
|
NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ACOX1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Acox2 |
acyl-CoA oxidase 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of ACOX2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160
|
|
G |
Acp1 |
acid phosphatase 1 |
decreases expression |
ISO |
Gold results in decreased expression of ACP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:47,506,380...47,522,021
Ensembl chr 6:47,506,380...47,522,021
|
|
G |
Acvr1c |
activin A receptor type 1C |
decreases expression |
ISO |
Gold results in decreased expression of ACVR1C mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:42,815,490...42,892,423
Ensembl chr 3:42,822,610...42,892,327
|
|
G |
Adam28 |
ADAM metallopeptidase domain 28 |
increases expression |
ISO |
Gold results in increased expression of ADAM28 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr15:43,774,463...43,840,726
Ensembl chr15:42,944,467...43,840,672
|
|
G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
decreases expression |
ISO |
Gold results in decreased expression of ADH5 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:226,975,184...226,987,591
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Adipor2 |
adiponectin receptor 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ADIPOR2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Adra1b |
adrenoceptor alpha 1B |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of ADRA1B mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:28,255,025...28,373,418
Ensembl chr10:28,255,025...28,312,919
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of ADRB2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Ahsg |
alpha-2-HS-glycoprotein |
decreases expression |
ISO |
Gold analog results in decreased expression of AHSG mRNA |
CTD |
PMID:36057382 |
|
NCBI chr11:78,121,388...78,127,998
Ensembl chr11:78,117,918...78,145,999
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
increases expression |
ISO |
Gold results in increased expression of AIFM1 protein |
CTD |
PMID:25462594 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
decreases expression |
ISO |
Gold results in decreased expression of AIMP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:221,151,907...221,175,458
Ensembl chr 2:221,151,904...221,175,728
|
|
G |
Ak3 |
adenylate kinase 3 |
decreases expression |
ISO |
Gold results in decreased expression of AK3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
|
|
G |
Akap13 |
A-kinase anchoring protein 13 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of AKAP13 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:129,313,183...129,619,647
Ensembl chr 1:129,314,402...129,619,646
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
Gold results in increased expression of AKR1B10 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Gold results in increased expression of AKR1C2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
increases expression |
ISO |
Gold results in increased expression of AKR1C3 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:27470402 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
multiple interactions increases expression |
ISO |
ALB protein results in increased uptake of [Polyethylene Glycols binds to Gold]; ALB protein results in increased uptake of [Polyethyleneimine binds to Gold]; ALB protein results in increased uptake of [Thioctic Acid binds to Gold] Gold analog results in increased expression of ALB mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Anxa5 |
annexin A5 |
increases expression |
ISO |
Gold analog results in increased expression of ANXA5 protein |
CTD |
PMID:24780912 |
|
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of APAF1 mRNA; [Quercetin analog co-treated with Gold analog] results in increased expression of APAF1 protein Gold analog results in decreased expression of APAF1 mRNA |
CTD |
PMID:27470402 PMID:28433809 PMID:36057382 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of APEX1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Apoa4 |
apolipoprotein A4 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of APOA4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Aprt |
adenine phosphoribosyl transferase |
decreases expression |
ISO |
Gold analog results in decreased expression of APRT protein |
CTD |
PMID:24780912 |
|
NCBI chr19:50,626,201...50,628,491
Ensembl chr19:50,626,202...50,628,431
|
|
G |
Aqp4 |
aquaporin 4 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of AQP4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Arl1 |
ARF like GTPase 1 |
decreases expression |
ISO |
Gold results in decreased expression of ARL1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:23,120,004...23,131,173
Ensembl chr 7:23,119,589...23,131,898
|
|
G |
Arl5b |
ARF like GTPase 5B |
decreases expression |
ISO |
Gold results in decreased expression of ARL5B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr17:77,955,864...77,979,895
Ensembl chr17:77,955,818...77,979,854
|
|
G |
Arsg |
arylsulfatase G |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ARSG mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:94,412,261...94,551,224
Ensembl chr10:94,447,399...94,542,941
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of ASAH1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
|
|
G |
Atf1 |
activating transcription factor 1 |
decreases expression |
ISO |
Gold results in decreased expression of ATF1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:131,361,962...131,404,677
Ensembl chr 7:131,362,450...131,404,670
|
|
G |
Atf4 |
activating transcription factor 4 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ATF4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
increases cleavage |
ISO |
Gold analog results in increased cleavage of ATF6 protein |
CTD |
PMID:26551149 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atic |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
decreases expression |
ISO |
Gold analog results in decreased expression of ATIC protein |
CTD |
PMID:24780912 |
|
NCBI chr 9:73,164,846...73,184,897
Ensembl chr 9:73,164,846...73,184,889
|
|
G |
Atl2 |
atlastin GTPase 2 |
decreases expression |
ISO |
Gold results in decreased expression of ATL2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:15,139,071...15,180,421
Ensembl chr 6:15,139,044...15,180,421
|
|
G |
Atm |
ATM serine/threonine kinase |
decreases expression |
ISO |
Gold analog results in decreased expression of ATM mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp2b1 |
ATPase plasma membrane Ca2+ transporting 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ATP2B1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:33,735,595...33,845,226
Ensembl chr 7:33,735,871...33,843,295
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
multiple interactions |
ISO |
Gold analog results in increased expression of and results in decreased phosphorylation of ATP5F1B protein |
CTD |
PMID:24780912 |
|
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
|
|
G |
Atp6v1g2 |
ATPase H+ transporting V1 subunit G2 |
decreases expression |
ISO |
Gold analog results in decreased expression of ATP6V1G2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr20:3,587,681...3,591,309
Ensembl chr20:3,587,686...3,590,481
|
|
G |
Atr |
ATR serine/threonine kinase |
decreases expression |
ISO |
Gold analog results in decreased expression of ATR mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
|
|
G |
Bace1 |
beta-secretase 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of BACE1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in increased expression of BAD protein |
CTD |
PMID:27470402 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Baiap2 |
BAR/IMD domain containing adaptor protein 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of BAIAP2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:105,223,065...105,290,130
Ensembl chr10:105,223,090...105,290,134
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression |
ISO |
Gold results in increased expression of BAK1 mRNA |
CTD |
PMID:22178767 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO EXP |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which affects the localization of BAX protein; [Gold analog co-treated with Platinum] results in increased expression of BAX mRNA; [Polyethyleneimine binds to Gold] which results in decreased expression of BAX mRNA; [Quercetin analog co-treated with Gold analog] results in increased expression of BAX protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of BAX protein Gold results in increased expression of BAX mRNA |
CTD |
PMID:21621595 PMID:22178767 PMID:25846798 PMID:27470402 PMID:27836789 PMID:28433809 More...
|
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcas2 |
BCAS2, pre-mRNA processing factor |
decreases expression |
ISO |
Gold results in decreased expression of BCAS2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:190,692,503...190,700,386
Ensembl chr 2:190,692,461...190,700,389
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO EXP |
[Gold analog co-treated with Platinum] results in decreased expression of BCL2 mRNA; [Quercetin analog co-treated with Gold analog] results in decreased expression of BCL2 protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in decreased expression of BCL2 protein |
CTD |
PMID:25846798 PMID:27470402 PMID:27836789 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of BCL2L1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
decreases expression |
ISO |
Gold analog results in decreased expression of BCL2L11 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
decreases expression |
ISO |
Gold results in decreased expression of BIRC2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
decreases expression |
ISO |
Gold analog results in decreased expression of BIRC3 mRNA; Gold results in decreased expression of BIRC3 mRNA |
CTD |
PMID:25523186 PMID:36057382 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Bmal1 |
basic helix-loop-helix ARNT like 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of BMAL1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
|
|
G |
Bmi1 |
BMI1 proto-oncogene, polycomb ring finger |
decreases expression |
ISO |
Gold results in decreased expression of BMI1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr17:81,332,175...81,341,625
Ensembl chr17:81,332,214...81,388,690
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of BRCA1 mRNA Gold analog results in decreased expression of BRCA1 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of BRCA2 mRNA Gold analog results in decreased expression of BRCA2 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
C1d |
C1D nuclear receptor corepressor |
decreases expression |
ISO |
Gold results in decreased expression of C1D mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:91,660,951...91,673,177
Ensembl chr14:91,660,989...91,672,852
|
|
G |
C3 |
complement C3 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of C3 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C8h11orf54 |
similar to human chromosome 11 open reading frame 54 |
decreases expression |
ISO |
Gold results in decreased expression of C11ORF54 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473
|
|
G |
C9 |
complement C9 |
decreases expression |
ISO |
Gold analog results in decreased expression of C9 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338
|
|
G |
Capza2 |
capping actin protein of muscle Z-line subunit alpha 2 |
decreases expression |
ISO |
Gold results in decreased expression of CAPZA2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:45,978,142...46,014,032
Ensembl chr 4:45,977,807...46,013,864
|
|
G |
Car13 |
carbonic anhydrase 13 |
decreases expression |
ISO |
Gold results in decreased expression of CA13 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:86,928,401...86,959,525
Ensembl chr 2:86,928,383...86,959,525
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of CASP1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity increases cleavage increases expression |
ISO EXP |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which results in increased activity of CASP3 protein; [Gold analog co-treated with Platinum] results in increased activity of CASP3 protein; [Gold analog co-treated with Platinum] results in increased expression of CASP3 mRNA; [Polyethyleneimine binds to Gold] which results in increased expression of CASP3 mRNA; [Quercetin analog co-treated with Gold analog] results in increased cleavage of CASP3 protein; [Quercetin analog co-treated with Gold analog] results in increased expression of and results in increased activity of CASP3 protein; Dexamethasone promotes the reaction [Gold results in increased activity of CASP3 protein]; Etoposide promotes the reaction [Gold results in increased activity of CASP3 protein] [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of CASP3 protein Gold analog results in increased cleavage of CASP3 protein Gold results in increased expression of CASP3 mRNA |
CTD |
PMID:19760634 PMID:21621595 PMID:22178767 PMID:25846798 PMID:26551149 PMID:27470402 PMID:27836789 PMID:28433809 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
increases cleavage |
ISO |
Gold analog results in increased cleavage of CASP4 protein |
CTD |
PMID:26551149 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp7 |
caspase 7 |
increases cleavage |
ISO |
Gold analog results in increased cleavage of CASP7 protein |
CTD |
PMID:26551149 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
increases expression decreases expression |
ISO |
Gold results in increased expression of CASP8 mRNA Gold analog results in decreased expression of CASP8 mRNA |
CTD |
PMID:22178767 PMID:36057382 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases cleavage |
ISO EXP |
[Gold analog co-treated with Platinum] results in increased activity of CASP9 protein; [Gold analog co-treated with Platinum] results in increased expression of CASP9 mRNA Gold analog results in increased cleavage of CASP9 protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of CASP9 protein |
CTD |
PMID:25846798 PMID:26551149 PMID:27836789 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
[Gold binds to NKCT1 protein, Naja kaouthia] inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein] |
CTD |
PMID:27836789 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbx3 |
chromobox 3 |
decreases expression |
ISO |
Gold results in decreased expression of CBX3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:80,545,450...80,559,284
Ensembl chr 4:80,546,010...80,559,283 Ensembl chr 4:80,546,010...80,559,283
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL2 protein Gold results in increased secretion of CCL2 protein |
CTD |
PMID:22155353 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL5 protein Gold results in increased secretion of CCL5 protein |
CTD |
PMID:22155353 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL7 protein Gold results in increased secretion of CCL7 protein |
CTD |
PMID:22155353 |
|
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in decreased expression of CCND1 protein |
CTD |
PMID:27470402 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
decreases expression |
ISO |
Gold analog results in decreased expression of CCT5 protein |
CTD |
PMID:24780912 |
|
NCBI chr 2:82,591,750...82,602,903
Ensembl chr 2:82,590,630...82,602,930
|
|
G |
Cd19 |
CD19 molecule |
increases expression |
ISO |
Gold analog results in increased expression of CD19 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:180,987,286...180,993,920
Ensembl chr 1:180,987,286...180,993,975
|
|
G |
Cd36 |
CD36 molecule |
decreases expression |
ISO |
Gold analog results in decreased expression of CD36 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd40 |
CD40 molecule |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CD40 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd86 |
CD86 molecule |
decreases expression |
ISO |
Gold analog results in decreased expression of CD86 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cda |
cytidine deaminase |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CDA mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:150,556,615...150,583,231
Ensembl chr 5:150,556,615...150,583,231
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression increases expression |
ISO |
Gold results in decreased expression of CDK1 mRNA Gold results in increased expression of CDK1 mRNA |
CTD |
PMID:25523186 PMID:29705079 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk7 |
cyclin-dependent kinase 7 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CDK7 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 2:31,840,558...31,865,422
Ensembl chr 2:31,840,558...31,865,383
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
ISO |
[Gold binds to Dimethyldithiocarbamate] which results in increased expression of CDKN1B protein |
CTD |
PMID:17079469 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2aip |
CDKN2A interacting protein |
decreases expression |
ISO |
Gold results in decreased expression of CDKN2AIP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:44,536,147...44,546,216
Ensembl chr16:44,536,234...44,540,033
|
|
G |
Cgrrf1 |
cell growth regulator with ring finger domain 1 |
decreases expression |
ISO |
Gold results in decreased expression of CGRRF1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:20,088,564...20,109,042
Ensembl chr15:20,088,571...20,109,037
|
|
G |
Chek1 |
checkpoint kinase 1 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CHEK1 mRNA Gold analog results in decreased expression of CHEK1 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chek2 |
checkpoint kinase 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of CHEK2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Chordc1 |
cysteine and histidine rich domain containing 1 |
decreases expression |
ISO |
Gold results in decreased expression of CHORDC1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:15,374,471...15,399,162
|
|
G |
Cisd1 |
CDGSH iron sulfur domain 1 |
decreases expression |
ISO |
Gold results in decreased expression of CISD1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr20:17,255,302...17,268,688
Ensembl chr20:17,255,151...17,284,924
|
|
G |
Cldn12 |
claudin 12 |
decreases expression |
ISO |
Gold results in decreased expression of CLDN12 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:28,522,659...28,533,647
Ensembl chr 4:28,522,678...28,533,801
|
|
G |
Cnbp |
CCHC-type zinc finger, nucleic acid binding protein |
decreases expression |
ISO |
Gold results in decreased expression of CNBP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:120,302,768...120,311,694
Ensembl chr 4:120,302,771...120,311,637
|
|
G |
Cnot7 |
CCR4-NOT transcription complex, subunit 7 |
decreases expression |
ISO |
Gold results in decreased expression of CNOT7 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:51,775,416...51,794,581
Ensembl chr16:51,775,412...51,794,576
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
increases expression |
ISO |
Gold analog results in increased expression of COL1A1 protein |
CTD |
PMID:24780912 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of COL1A2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of COL3A1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Commd8 |
COMM domain containing 8 |
decreases expression |
ISO |
Gold results in decreased expression of COMMD8 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:36,049,040...36,059,617
Ensembl chr14:36,049,004...36,059,617
|
|
G |
Cox11 |
cytochrome c oxidase copper chaperone COX11 |
decreases expression |
ISO |
Gold results in decreased expression of COX11 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:75,458,735...75,465,322
Ensembl chr10:75,458,749...75,465,322
|
|
G |
Cox17 |
cytochrome c oxidase copper chaperone COX17 |
decreases expression |
ISO |
Gold results in decreased expression of COX17 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:62,400,733...62,406,507
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CPT1A mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CPT2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Crot |
carnitine O-octanoyltransferase |
decreases expression |
ISO |
Gold analog results in decreased expression of CROT mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CSF2 protein Gold results in increased secretion of CSF2 protein |
CTD |
PMID:22155353 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csf3 |
colony stimulating factor 3 |
increases secretion multiple interactions |
ISO |
Gold results in increased secretion of CSF3 protein [Gold co-treated with Silicon Dioxide] results in increased secretion of CSF3 protein |
CTD |
PMID:22155353 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Ctcf |
CCCTC-binding factor |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CTCF mRNA |
CTD |
PMID:19695318 |
|
NCBI chr19:33,521,726...33,571,124
Ensembl chr19:33,529,319...33,571,123
|
|
G |
Cux1 |
cut-like homeobox 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CUX1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr12:20,107,062...20,425,868
Ensembl chr12:20,107,311...20,425,866 Ensembl chr 4:20,107,311...20,425,866
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases secretion multiple interactions |
ISO |
Gold results in increased secretion of CXCL10 protein [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL10 protein |
CTD |
PMID:22155353 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CXCL2 mRNA; [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL2 protein Gold results in increased secretion of CXCL2 protein |
CTD |
PMID:19695318 PMID:22155353 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CXCL1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which affects the localization of CYCS protein |
CTD |
PMID:21621595 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases activity decreases expression multiple interactions |
ISO |
Gold analog results in increased activity of CYP1A1 protein Gold analog results in decreased expression of CYP1A1 mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of CYP1A1 mRNA |
CTD |
PMID:20193702 PMID:28433809 PMID:36057382 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
increases expression |
ISO |
Gold results in increased expression of CYP24A1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CYP2D6 mRNA Gold analog results in decreased expression of CYP2D6 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
increases expression |
ISO |
Gold analog results in increased expression of CYP7A1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cyth1 |
cytohesin 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CYTH1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:103,402,727...103,485,826
Ensembl chr10:103,366,145...103,485,760
|
|
G |
Dab2 |
DAB adaptor protein 2 |
increases expression |
ISO |
Gold results in increased expression of DAB2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 2:55,514,692...55,567,476
Ensembl chr 2:55,514,700...55,567,476
|
|
G |
Dcp2 |
decapping mRNA 2 |
decreases expression |
ISO |
Gold results in decreased expression of DCP2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr18:36,750,732...36,787,067
Ensembl chr18:36,750,732...36,788,557
|
|
G |
Ddc |
dopa decarboxylase |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of DDC mRNA |
CTD |
PMID:19695318 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of DDIT3 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of DDIT4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Defb1 |
defensin beta 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of DEFB1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
multiple interactions decreases expression |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of DHCR24 mRNA Gold analog results in decreased expression of DHCR24 mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of DHCR24 mRNA |
CTD |
PMID:19695318 PMID:28433809 PMID:36057382 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dld |
dihydrolipoamide dehydrogenase |
decreases expression |
ISO |
Gold analog results in decreased expression of DLD mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 6:47,904,153...47,924,814
Ensembl chr 6:47,903,914...47,924,795
|
|
G |
Dnah14 |
dynein axonemal heavy chain 14 |
decreases expression |
ISO |
Gold results in decreased expression of DNAH14 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:93,322,653...93,540,706
Ensembl chr13:93,322,711...93,538,646
|
|
G |
Dnaja3 |
DnaJ heat shock protein family (Hsp40) member A3 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of DNAJA3 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr10:10,854,732...10,880,171
Ensembl chr10:10,854,732...10,880,161
|
|
G |
Dnajb14 |
DnaJ heat shock protein family (Hsp40) member B14 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJB14 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:226,358,988...226,409,461
Ensembl chr 2:226,358,996...226,402,490
|
|
G |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJB6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:5,452,683...5,556,679
Ensembl chr 4:5,452,683...5,556,659
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJB9 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Dnajc10 |
DnaJ heat shock protein family (Hsp40) member C10 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJC10 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:65,232,031...65,272,732
Ensembl chr 3:65,232,697...65,272,719
|
|
G |
Dnajc19 |
DnaJ heat shock protein family (Hsp40) member C19 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJC19 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:116,923,272...116,945,312
Ensembl chr 2:116,923,272...116,945,264
|
|
G |
Dnajc21 |
DnaJ heat shock protein family (Hsp40) member C21 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJC21 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:59,419,507...59,446,746
Ensembl chr 2:59,419,510...59,446,752
|
|
G |
Dnajc5 |
DnaJ heat shock protein family (Hsp40) member C5 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of DNAJC5 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:168,621,905...168,656,570
Ensembl chr 3:168,621,969...168,655,935
|
|
G |
Dpysl4 |
dihydropyrimidinase-like 4 |
increases expression |
ISO |
Gold analog results in increased expression of DPYSL4 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:193,883,039...193,898,916
Ensembl chr 1:193,883,106...193,898,914
|
|
G |
Drd3 |
dopamine receptor D3 |
multiple interactions |
EXP |
Gold inhibits the reaction [3-N-methylspiperone binds to DRD3 protein] |
CTD |
PMID:10215675 |
|
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
|
|
G |
Drd4 |
dopamine receptor D4 |
multiple interactions |
EXP |
Gold inhibits the reaction [3-N-methylspiperone binds to DRD4 protein] |
CTD |
PMID:10215675 |
|
NCBI chr 1:196,396,366...196,400,824
Ensembl chr 1:196,396,366...196,399,553
|
|
G |
Dsc2 |
desmocollin 2 |
increases expression |
ISO |
Gold results in increased expression of DSC2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
|
|
G |
Dsg2 |
desmoglein 2 |
increases expression |
ISO |
Gold results in increased expression of DSG2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr18:11,846,207...11,904,630
Ensembl chr18:11,846,183...11,904,156
|
|
G |
Duox1 |
dual oxidase 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of DUOX1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:109,260,526...109,295,588
Ensembl chr 3:109,262,397...109,295,563
|
|
G |
Duox2 |
dual oxidase 2 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of DUOX2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of DUSP1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp11 |
dual specificity phosphatase 11 |
decreases expression |
ISO |
Gold results in decreased expression of DUSP11 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:118,367,673...118,385,183
Ensembl chr 4:118,368,053...118,385,181
|
|
G |
Dut |
deoxyuridine triphosphatase |
decreases expression |
ISO |
Gold results in decreased expression of DUT mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
|
|
G |
Dzip3 |
DAZ interacting zinc finger protein 3 |
decreases expression |
ISO |
Gold results in decreased expression of DZIP3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:51,823,235...51,893,353
Ensembl chr11:51,823,231...51,893,353
|
|
G |
Edem3 |
ER degradation enhancing alpha-mannosidase like protein 3 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of EDEM3 mRNA Gold analog results in decreased expression of EDEM3 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr13:63,858,282...63,920,538
Ensembl chr13:63,858,716...63,920,523
|
|
G |
Eea1 |
early endosome antigen 1 |
decreases expression |
ISO |
Gold results in decreased expression of EEA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:30,554,686...30,722,186
Ensembl chr 7:30,554,552...30,718,487
|
|
G |
Eef1d |
eukaryotic translation elongation factor 1 delta |
decreases expression |
ISO |
Gold analog results in decreased expression of EEF1D protein |
CTD |
PMID:24780912 |
|
NCBI chr 7:107,581,930...107,596,735
Ensembl chr 7:107,581,930...107,608,799
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of EEF2 protein |
CTD |
PMID:24780912 |
|
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased acetylation of and results in increased stability of EP300 protein]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of RELA protein]; EP300 protein inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]; MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]; MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]] |
CTD |
PMID:27634460 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] |
CTD |
PMID:27634460 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Ehhadh |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
decreases expression |
ISO |
Gold analog results in decreased expression of EHHADH mRNA |
CTD |
PMID:36057382 |
|
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
|
|
G |
Eid1 |
EP300 interacting inhibitor of differentiation 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of EID1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 3:112,922,961...112,924,680
Ensembl chr 3:112,922,668...112,924,752
|
|
G |
Eif1ax |
eukaryotic translation initiation factor 1A, X-linked |
decreases expression |
ISO |
Gold results in decreased expression of EIF1AX mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:35,498,698...35,513,402
Ensembl chr X:35,498,517...35,513,335
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases phosphorylation |
ISO |
Gold analog results in increased phosphorylation of EIF2AK3 protein |
CTD |
PMID:26551149 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
decreases expression |
ISO |
Gold results in decreased expression of EIF4A2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:77,764,126...77,770,810
Ensembl chr11:77,764,124...77,770,781
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in decreased expression of EIF4E protein |
CTD |
PMID:27470402 |
|
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
|
|
G |
Eif4ebp3 |
eukaryotic translation initiation factor 4E binding protein 3 |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in increased expression of EIF4EBP3 protein |
CTD |
PMID:27470402 |
|
NCBI chr18:28,263,089...28,268,033
Ensembl chr18:28,162,311...28,268,024
|
|
G |
Eif5b |
eukaryotic translation initiation factor 5B |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of EIF5B mRNA Gold analog results in decreased expression of EIF5B mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 9:40,222,769...40,277,482
Ensembl chr 9:40,222,898...40,277,482
|
|
G |
Eno1 |
enolase 1 |
multiple interactions |
ISO |
Gold analog results in decreased expression of and results in increased phosphorylation of ENO1 protein |
CTD |
PMID:24780912 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions |
ISO |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased acetylation of and results in increased stability of EP300 protein]; [Polyethyleneimine binds to Gold] which results in decreased expression of EP300 mRNA; EP300 protein inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]] |
CTD |
PMID:27634460 PMID:28433809 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epgn |
epithelial mitogen |
increases expression |
ISO |
Gold results in increased expression of EPGN mRNA |
CTD |
PMID:29705079 |
|
NCBI chr14:17,076,774...17,084,806
Ensembl chr14:17,076,774...17,084,806
|
|
G |
Epha1 |
Eph receptor A1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of EPHA1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 4:71,246,409...71,260,920
Ensembl chr 4:71,246,409...71,260,846
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
ISO |
Gold analog results in increased expression of EPHX1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ERCC2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
decreases expression |
ISO |
Gold analog results in decreased expression of ERCC6 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
increases phosphorylation |
ISO |
Gold analog results in increased phosphorylation of ERN1 protein |
CTD |
PMID:26551149 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Ern2 |
endoplasmic reticulum to nucleus signaling 2 |
increases expression |
ISO |
Gold analog results in increased expression of ERN2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:176,726,454...176,743,289
Ensembl chr 1:176,726,454...176,743,289
|
|
G |
Ero1a |
endoplasmic reticulum oxidoreductase 1 alpha |
increases expression |
ISO |
Gold results in increased expression of ERO1A mRNA |
CTD |
PMID:29705079 |
|
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
|
|
G |
Esco2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
decreases expression |
ISO |
Gold results in decreased expression of ESCO2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of ESR1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Evi5 |
ecotropic viral integration site 5 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of EVI5 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr14:1,875,601...2,021,678
Ensembl chr14:1,875,647...2,021,678
|
|
G |
Evx1 |
even-skipped homeobox 1 |
increases expression |
ISO |
Gold results in increased expression of EVX1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:81,416,590...81,420,967
Ensembl chr 4:81,416,590...81,420,967
|
|
G |
Fancl |
FA complementation group L |
decreases expression |
ISO |
Gold results in decreased expression of FANCL mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:100,249,733...100,317,958
Ensembl chr14:100,248,875...100,314,255
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of FAS mRNA Gold analog results in decreased expression of FAS mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
ISO |
Gold analog results in decreased expression of FASN mRNA |
CTD |
PMID:36057382 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of FGF1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fh |
fumarate hydratase |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of FH mRNA |
CTD |
PMID:28433809 |
|
NCBI chr13:87,524,331...87,550,215
Ensembl chr13:87,524,337...87,550,266
|
|
G |
Fkbp9 |
FKBP prolyl isomerase 9 |
increases phosphorylation decreases expression |
ISO |
Gold analog results in increased phosphorylation of FKBP9 protein Gold analog results in decreased expression of FKBP9 protein |
CTD |
PMID:24780912 |
|
NCBI chr 4:86,106,256...86,156,723
Ensembl chr 4:86,106,282...86,156,721
|
|
G |
Fmo5 |
flavin containing dimethylaniline monoxygenase 5 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of FMO5 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased expression of FOS mRNA Gold results in increased expression of FOS mRNA |
CTD |
PMID:22155353 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
Gold results in increased expression of FTH1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Fyb1 |
FYN binding protein 1 |
increases expression |
ISO |
Gold results in increased expression of FYB1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 2:55,621,585...55,781,206
Ensembl chr 2:55,632,698...55,779,629
|
|
G |
Fzd4 |
frizzled class receptor 4 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of FZD4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:143,279,934...143,288,799
Ensembl chr 1:143,280,065...143,285,724
|
|
G |
G2e3 |
G2/M-phase specific E3 ubiquitin protein ligase |
decreases expression |
ISO |
Gold results in decreased expression of G2E3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:68,763,847...68,795,305
Ensembl chr 6:68,764,185...68,793,924
|
|
G |
Galnt1 |
polypeptide N-acetylgalactosaminyltransferase 1 |
decreases expression |
ISO |
Gold results in decreased expression of GALNT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr18:15,489,015...15,568,849
Ensembl chr18:15,489,020...15,568,245
|
|
G |
Galnt5 |
polypeptide N-acetylgalactosaminyltransferase 5 |
decreases expression |
ISO |
Gold analog results in decreased expression of GALNT5 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:42,573,622...42,619,881
Ensembl chr 3:42,573,622...42,619,881
|
|
G |
Ganc |
glucosidase, alpha; neutral C |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of GANC mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 3:107,353,369...107,406,104
Ensembl chr 3:107,353,369...107,405,241
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
decreases expression |
ISO |
Gold analog results in decreased expression of GAPDH protein |
CTD |
PMID:24780912 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gca |
grancalcin |
decreases expression |
ISO |
Gold results in decreased expression of GCA mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:47,297,320...47,329,913
Ensembl chr 3:47,297,383...47,328,581
|
|
G |
Gcdh |
glutaryl-CoA dehydrogenase |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of GCDH mRNA |
CTD |
PMID:28433809 |
|
NCBI chr19:23,263,215...23,269,689
Ensembl chr19:23,263,264...23,269,681
|
|
G |
Gmps |
guanine monophosphate synthase |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of GMPS mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 2:148,441,369...148,491,908
Ensembl chr 2:148,435,643...148,485,875
|
|
G |
Gng10 |
G protein subunit gamma 10 |
decreases expression |
ISO |
Gold results in decreased expression of GNG10 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:73,856,124...73,863,017
Ensembl chr 5:73,856,164...73,863,012 Ensembl chr 5:73,856,164...73,863,012
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of GOT2 protein |
CTD |
PMID:24780912 |
|
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
|
|
G |
Gpr182 |
G protein-coupled receptor 182 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of GPR182 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:63,585,997...63,589,088
Ensembl chr 7:63,578,750...63,589,210
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions decreases expression |
ISO |
[Gold binds to NKCT1 protein, Naja kaouthia] inhibits the reaction [Diethylnitrosamine results in increased activity of GPT protein]; [Gold binds to NKCT1 protein, Naja kaouthia] inhibits the reaction [Diethylnitrosamine results in increased expression of GPT protein] Gold analog results in decreased expression of GPT mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of GPT mRNA |
CTD |
PMID:27836789 PMID:28433809 PMID:36057382 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases expression |
ISO |
Gold analog results in increased expression of GPX2 mRNA; Gold results in increased expression of GPX2 mRNA |
CTD |
PMID:25523186 PMID:36057382 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression |
ISO |
Gold analog results in increased expression of GPX3 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gsn |
gelsolin |
decreases expression increases degradation |
ISO |
Gold analog results in decreased expression of GSN protein Gold analog results in increased degradation of GSN protein |
CTD |
PMID:24780912 PMID:26551149 |
|
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
multiple interactions increases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of GSTM4 mRNA Gold analog results in increased expression of GSTM4 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
|
|
G |
Haao |
3-hydroxyanthranilate 3,4-dioxygenase |
increases expression |
ISO |
Gold analog results in increased expression of HAAO mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 6:10,845,235...10,864,863
Ensembl chr 6:10,845,771...10,864,877
|
|
G |
Hat1 |
histone acetyltransferase 1 |
decreases expression |
ISO |
Gold results in decreased expression of HAT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:56,217,344...56,265,021
Ensembl chr 3:56,217,342...56,275,517
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
multiple interactions |
ISO |
[Polyethylene Glycols binds to Gold] which results in increased expression of HAVCR1 protein; [Polyethyleneimine binds to Gold] which results in increased expression of HAVCR1 protein; [Thioctic Acid binds to Gold] which results in increased expression of HAVCR1 protein |
CTD |
PMID:28433809 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
increases expression |
ISO |
Gold results in increased expression of HCAR2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr12:32,726,252...32,728,238
Ensembl chr12:32,726,184...32,728,504
|
|
G |
Hexb |
hexosaminidase subunit beta |
multiple interactions |
EXP |
[gold chloride results in increased abundance of Gold] which results in increased export of HEXB protein; [gold tetrachloride, acid results in increased abundance of Gold] which results in increased export of HEXB protein |
CTD |
PMID:21376117 |
|
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
|
|
G |
Hmgb2 |
high mobility group box 2 |
decreases expression |
ISO |
Gold results in decreased expression of HMGB2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140 Ensembl chr 1:32,710,658...32,713,140
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
Gold results in increased expression of HMOX1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hoxa3 |
homeobox A3 |
decreases expression |
ISO |
Gold analog results in decreased expression of HOXA3 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 4:81,269,243...81,313,218
Ensembl chr 4:81,269,243...81,313,218
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
decreases expression |
ISO |
Gold results in decreased expression of HPRT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
|
|
G |
Hpx |
hemopexin |
decreases expression |
ISO |
Gold analog results in decreased expression of HPX mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:159,932,819...159,940,327
Ensembl chr 1:159,932,755...159,940,328
|
|
G |
Hsbp1 |
heat shock factor binding protein 1 |
decreases expression |
ISO |
Gold results in decreased expression of HSBP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr19:47,401,039...47,405,373
Ensembl chr19:47,400,966...47,435,821
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of HSF1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of HSP90AB1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
|
|
G |
Hspa13 |
heat shock protein family A (Hsp70) member 13 |
decreases expression |
ISO |
Gold results in decreased expression of HSPA13 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:14,375,669...14,389,853
Ensembl chr11:14,373,275...14,389,895
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of HSPA1A mRNA |
CTD |
PMID:28433809 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of HSPA1B mRNA |
CTD |
PMID:28433809 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of HSPA2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Hspa4 |
heat shock protein family A (Hsp70) member 4 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of HSPA4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
increases expression |
ISO |
Gold analog results in increased expression of HSPA8 protein |
CTD |
PMID:24780912 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of HSPA9 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of HSPB1 mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of HSPB1 mRNA |
CTD |
PMID:19695318 PMID:28433809 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of HSPD1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
increases expression |
ISO |
Gold results in increased expression of HTATIP2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
|
|
G |
Htatsf1 |
HIV-1 Tat specific factor 1 |
decreases expression |
ISO |
Gold results in decreased expression of HTATSF1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:134,935,426...134,949,607
Ensembl chr X:134,935,426...134,949,607
|
|
G |
Htra4 |
HtrA serine peptidase 4 |
decreases expression |
ISO |
Gold analog results in decreased expression of HTRA4 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr16:67,001,605...67,015,074
Ensembl chr16:67,001,605...67,015,074
|
|
G |
Hyou1 |
hypoxia up-regulated 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of HYOU1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 8:44,706,073...44,718,189
Ensembl chr 8:44,706,263...44,718,186
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
multiple interactions |
ISO |
Gold analog results in decreased expression of and results in increased phosphorylation of IDH1 protein |
CTD |
PMID:24780912 |
|
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
|
|
G |
Idh3g |
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of IDH3G mRNA |
CTD |
PMID:28433809 |
|
NCBI chr X:151,515,244...151,524,175
Ensembl chr X:151,515,247...151,524,171
|
|
G |
Ifngr1 |
interferon gamma receptor 1 |
increases expression |
ISO |
Gold results in increased expression of IFNGR1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 1:14,333,167...14,351,799
Ensembl chr 1:14,333,187...14,351,785
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions |
ISO |
Gold inhibits the reaction [IGF1 protein binds to IGF1R protein] |
CTD |
PMID:9648927 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
multiple interactions |
ISO |
Gold inhibits the reaction [IGF1 protein binds to IGF1R protein]; Gold inhibits the reaction [IGF2 protein binds to IGF1R protein] |
CTD |
PMID:9648927 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igf2 |
insulin-like growth factor 2 |
multiple interactions |
ISO |
Gold inhibits the reaction [IGF2 protein binds to IGF1R protein] |
CTD |
PMID:9648927 |
|
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Ikzf2 |
IKAROS family zinc finger 2 |
decreases expression |
ISO |
Gold results in decreased expression of IKZF2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:71,046,038...71,191,296
Ensembl chr 9:71,042,440...71,190,867
|
|
G |
Il10 |
interleukin 10 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of IL10 protein Gold results in increased secretion of IL10 protein |
CTD |
PMID:22155353 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions decreases expression increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of IL1A protein Gold analog results in decreased expression of IL1A mRNA Gold results in increased secretion of IL1A protein |
CTD |
PMID:22155353 PMID:36057382 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases expression increases secretion |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of IL1B mRNA; [Gold co-treated with Silicon Dioxide] results in increased secretion of IL1B protein Gold analog results in decreased expression of IL1B mRNA Gold results in increased secretion of IL1B protein |
CTD |
PMID:19695318 PMID:22155353 PMID:36057382 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il4 |
interleukin 4 |
decreases expression |
ISO |
Gold analog results in decreased expression of IL4 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of IL6 mRNA; [Gold co-treated with Silicon Dioxide] results in increased secretion of IL6 protein [Polyethylene Glycols binds to Gold] which results in increased expression of IL6 protein; [Polyethyleneimine binds to Gold] which results in increased expression of IL6 protein; [Thioctic Acid binds to Gold] which results in increased expression of IL6 protein Gold results in increased secretion of IL6 protein |
CTD |
PMID:19695318 PMID:22155353 PMID:28433809 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6r |
interleukin 6 receptor |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of IL6RA mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Impa1 |
inositol monophosphatase 1 |
decreases expression |
ISO |
Gold results in decreased expression of IMPA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:91,462,781...91,484,057
Ensembl chr 2:91,462,799...91,484,313
|
|
G |
Ipmk |
inositol polyphosphate multikinase |
decreases expression |
ISO |
Gold results in decreased expression of IPMK mRNA |
CTD |
PMID:25523186 |
|
NCBI chr20:17,216,988...17,251,675
Ensembl chr20:17,218,037...17,251,705
|
|
G |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of IQGAP2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 2:26,894,836...27,170,270
Ensembl chr 2:26,894,825...27,170,279
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of JAG1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
|
|
G |
Jak2 |
Janus kinase 2 |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in decreased phosphorylation of JAK2 protein |
CTD |
PMID:27470402 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]; MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]] |
CTD |
PMID:27634460 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Jup |
junction plakoglobin |
decreases expression |
ISO |
Gold analog results in decreased expression of JUP protein |
CTD |
PMID:24780912 |
|
NCBI chr10:85,300,438...85,327,378
Ensembl chr10:85,300,440...85,327,057
|
|
G |
Khk |
ketohexokinase |
increases expression |
ISO |
Gold analog results in increased expression of KHK mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 6:25,445,298...25,455,834
Ensembl chr 6:25,445,300...25,455,717
|
|
G |
Kin |
Kin17 DNA and RNA binding protein |
decreases expression |
ISO |
Gold results in decreased expression of KIN mRNA |
CTD |
PMID:25523186 |
|
NCBI chr17:68,413,483...68,431,392
Ensembl chr17:68,413,486...68,423,845
|
|
G |
Kitlg |
KIT ligand |
decreases expression |
ISO |
Gold results in decreased expression of KITLG mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Krr1 |
KRR1, small subunit processome component homolog |
decreases expression |
ISO |
Gold results in decreased expression of KRR1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:47,475,557...47,486,996
Ensembl chr 7:47,475,557...47,486,985
|
|
G |
Kynu |
kynureninase |
increases expression |
ISO |
Gold results in increased expression of KYNU mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488
|
|
G |
Lacc1 |
laccase domain containing 1 |
increases expression |
ISO |
Gold results in increased expression of LACC1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr15:52,390,267...52,407,630
Ensembl chr15:52,395,183...52,407,545
|
|
G |
Lactb2 |
lactamase, beta 2 |
decreases expression |
ISO |
Gold results in decreased expression of LACTB2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:5,569,080...5,591,843
Ensembl chr 5:5,569,067...5,596,429
|
|
G |
Larp1b |
La ribonucleoprotein 1B |
decreases expression |
ISO |
Gold results in decreased expression of LARP1B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:123,936,057...123,969,254
Ensembl chr 2:123,935,983...123,968,896
|
|
G |
Lif |
LIF, interleukin 6 family cytokine |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of LIF protein Gold results in increased secretion of LIF protein |
CTD |
PMID:22155353 |
|
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
|
|
G |
Lig4 |
DNA ligase 4 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which affects the expression of LIG4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr16:79,518,393...79,526,956
Ensembl chr16:79,518,312...79,527,040
|
|
G |
Lima1 |
LIM domain and actin binding 1 |
decreases expression |
ISO |
Gold results in decreased expression of LIMA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:130,901,717...131,001,512
Ensembl chr 7:130,901,717...131,001,473
|
|
G |
Lman1 |
lectin, mannose-binding, 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of LMAN1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr18:59,508,996...59,530,873
Ensembl chr18:59,508,996...59,530,851
|
|
G |
Lmna |
lamin A/C |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of LMNA mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
|
|
G |
Lmnb1 |
lamin B1 |
increases degradation |
ISO |
Gold analog results in increased degradation of LMNB1 protein |
CTD |
PMID:26551149 |
|
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Lpgat1 |
lysophosphatidylglycerol acyltransferase 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of LPGAT1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr13:103,294,622...103,365,372
Ensembl chr13:103,294,528...103,362,333
|
|
G |
Lratd1 |
LRAT domain containing 1 |
increases expression |
ISO |
Gold results in increased expression of LRATD1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:36,916,969...36,922,143
Ensembl chr 6:36,913,469...36,922,319
|
|
G |
Lsm5 |
LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated |
decreases expression |
ISO |
Gold results in decreased expression of LSM5 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:85,951,073...85,954,289
Ensembl chr 6:104,652,477...104,654,165 Ensembl chr 4:104,652,477...104,654,165
|
|
G |
Lsm6 |
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated |
decreases expression |
ISO |
Gold results in decreased expression of LSM6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr19:29,098,254...29,112,858
Ensembl chr13:42,114,032...42,116,484 Ensembl chr19:42,114,032...42,116,484
|
|
G |
Lss |
lanosterol synthase |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of LSS mRNA |
CTD |
PMID:28433809 |
|
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
|
|
G |
Mad2l1 |
mitotic arrest deficient 2 like 1 |
decreases expression |
ISO |
Gold results in decreased expression of MAD2L1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:95,906,692...95,918,885
Ensembl chr 4:95,906,817...95,913,470
|
|
G |
Map1b |
microtubule-associated protein 1B |
increases expression |
ISO |
Gold results in increased expression of MAP1B mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 2:30,817,261...30,910,458
Ensembl chr 2:30,817,261...30,910,317
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
multiple interactions |
ISO |
MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]; MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]] |
CTD |
PMID:27634460 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Mbnl2 |
muscleblind-like splicing regulator 2 |
decreases expression |
ISO |
Gold results in decreased expression of MBNL2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:97,385,278...97,542,924
Ensembl chr15:97,385,244...97,542,937
|
|
G |
Mdh1b |
malate dehydrogenase 1B |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of MDH1B mRNA Gold analog results in decreased expression of MDH1B mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 9:65,120,370...65,168,008
Ensembl chr 9:65,119,029...65,167,933
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
decreases expression |
ISO |
Gold analog results in decreased expression of MDM2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Mecr |
mitochondrial trans-2-enoyl-CoA reductase |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of MECR mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:144,029,684...144,056,373
Ensembl chr 5:144,029,731...144,055,863
|
|
G |
Mefv |
MEFV innate immunity regulator, pyrin |
increases expression |
ISO |
Gold results in increased expression of MEFV mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:11,786,948...11,796,977
Ensembl chr10:11,787,422...11,796,973
|
|
G |
Metap2 |
methionyl aminopeptidase 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of METAP2 mRNA; Gold results in decreased expression of METAP2 mRNA |
CTD |
PMID:25523186 PMID:36057382 |
|
NCBI chr 7:28,412,429...28,440,458
Ensembl chr 7:28,411,608...28,440,434
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of MKI67 mRNA Gold analog results in decreased expression of MKI67 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mmgt1 |
membrane magnesium transporter 1 |
decreases expression |
ISO |
Gold results in decreased expression of MMGT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:134,408,463...134,420,798
Ensembl chr X:134,408,466...134,420,729
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
increases expression |
ISO |
Gold results in increased expression of MMP3 mRNA |
CTD |
PMID:24022940 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]; EP300 protein inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]; MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]] |
CTD |
PMID:27634460 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mnat1 |
MNAT1 component of CDK activating kinase |
decreases expression |
ISO |
Gold results in decreased expression of MNAT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:91,814,703...91,971,945
Ensembl chr 6:91,814,749...91,970,744
|
|
G |
Mob1b |
MOB kinase activator 1B |
decreases expression |
ISO |
Gold results in decreased expression of MOB1B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:19,333,058...19,365,845
Ensembl chr14:19,332,459...19,365,845
|
|
G |
Mob4 |
MOB family member 4, phocein |
decreases expression |
ISO |
Gold results in decreased expression of MOB4 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:56,617,374...56,641,336
Ensembl chr 9:56,617,368...56,641,329
|
|
G |
Morc3 |
MORC family CW-type zinc finger 3 |
decreases expression |
ISO |
Gold results in decreased expression of MORC3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:33,151,906...33,194,650
Ensembl chr11:33,152,025...33,194,646
|
|
G |
Mrpl3 |
mitochondrial ribosomal protein L3 |
decreases expression |
ISO |
Gold results in decreased expression of MRPL3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:105,670,184...105,693,544
Ensembl chr 8:105,670,184...105,693,544
|
|
G |
Mrps6 |
mitochondrial ribosomal protein S6 |
decreases expression |
ISO |
Gold results in decreased expression of MRPS6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:31,295,358...31,348,483
Ensembl chr11:31,295,614...31,348,484
|
|
G |
Mt1-ps3 |
metallothionein 1, pseudogene 3 |
increases expression |
ISO |
Gold results in increased expression of MT1E mRNA |
CTD |
PMID:25523186 |
|
NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135
|
|
G |
Mt2A |
metallothionein 2A |
increases expression |
ISO |
Gold results in increased expression of MT2A mRNA |
CTD |
PMID:25523186 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of MTHFR mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
|
|
G |
Mtmr6 |
myotubularin related protein 6 |
decreases expression |
ISO |
Gold results in decreased expression of MTMR6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:34,419,931...34,457,863
Ensembl chr15:34,419,903...34,457,861
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in decreased phosphorylation of MTOR protein |
CTD |
PMID:27470402 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mtss1 |
MTSS I-BAR domain containing 1 |
increases expression |
ISO |
Gold results in increased expression of MTSS1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 7:90,488,751...90,628,007
Ensembl chr 7:90,488,754...90,627,968
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of MTTP mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
|
|
G |
Mycl |
MYCL proto-oncogene, bHLH transcription factor |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of MYCL mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:135,274,713...135,281,584
Ensembl chr 5:135,274,748...135,281,582
|
|
G |
Mynn |
myoneurin |
decreases expression |
ISO |
Gold results in decreased expression of MYNN mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:112,779,654...112,797,188
Ensembl chr 2:112,779,657...112,796,397
|
|
G |
Napepld |
N-acyl phosphatidylethanolamine phospholipase D |
decreases expression |
ISO |
Gold results in decreased expression of NAPEPLD mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:13,360,532...13,398,815
Ensembl chr 4:13,361,006...13,398,748
|
|
G |
Nceh1 |
neutral cholesterol ester hydrolase 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of NCEH1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 2:110,074,985...110,135,592
Ensembl chr 2:110,074,957...110,135,588
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases activity increases expression |
ISO |
Gold results in increased activity of NFE2L2 promoter Gold analog results in increased expression of NFE2L2 mRNA; Gold analog results in increased expression of NFE2L2 protein |
CTD |
PMID:21643505 PMID:36057382 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of NFKB1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbid |
NFKB inhibitor delta |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of NFKBID mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:85,679,353...85,690,415
Ensembl chr 1:85,680,861...85,690,447
|
|
G |
Nfkbiz |
NFKB inhibitor zeta |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of NFKBIZ mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
|
|
G |
Nipbl |
NIPBL, cohesin loading factor |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of NIPBL mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 2:57,399,443...57,586,770
Ensembl chr 2:57,399,445...57,565,899
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases expression |
ISO |
Gold results in increased expression of NOS2 protein |
CTD |
PMID:24022940 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nploc4 |
NPL4 homolog, ubiquitin recognition factor |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of NPLOC4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr10:105,654,395...105,709,958
Ensembl chr10:105,654,812...105,709,913
|
|
G |
Npm1 |
nucleophosmin 1 |
decreases expression |
ISO |
Gold results in decreased expression of NPM1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645 Ensembl chr X:17,739,941...17,751,645
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions increases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of NQO1 mRNA Gold analog results in increased expression of NQO1 mRNA; Gold results in increased expression of NQO1 mRNA |
CTD |
PMID:28433809 PMID:29705079 PMID:36057382 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of NR0B2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of NR4A1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Nrcam |
neuronal cell adhesion molecule |
increases expression |
ISO |
Gold results in increased expression of NRCAM mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 6:61,402,813...61,698,536
Ensembl chr 6:61,329,863...61,702,992
|
|
G |
Nrip1 |
nuclear receptor interacting protein 1 |
increases expression |
ISO |
Gold results in increased expression of NRIP1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr11:14,895,843...14,979,490
Ensembl chr11:14,895,553...14,981,761
|
|
G |
Ntn4 |
netrin 4 |
increases expression |
ISO |
Gold results in increased expression of NTN4 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 7:28,186,611...28,300,390
Ensembl chr 7:28,186,611...28,300,390
|
|
G |
Nucb1 |
nucleobindin 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of NUCB1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 1:95,968,325...95,999,183
Ensembl chr 1:95,968,326...96,003,220
|
|
G |
Nudt1 |
nudix hydrolase 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of NUDT1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr12:14,302,514...14,309,559
Ensembl chr12:14,302,694...14,305,826
|
|
G |
Nudt12 |
nudix hydrolase 12 |
decreases expression |
ISO |
Gold results in decreased expression of NUDT12 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:98,741,627...98,755,039
Ensembl chr 9:98,742,360...98,755,039
|
|
G |
Nudt13 |
nudix hydrolase 13 |
decreases expression |
ISO |
Gold analog results in decreased expression of NUDT13 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr15:4,001,787...4,022,404
Ensembl chr15:4,001,794...4,022,293
|
|
G |
Nup210 |
nucleoporin 210 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of NUP210 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 4:123,511,558...123,609,874
Ensembl chr 4:123,511,559...123,609,874
|
|
G |
Obi1 |
ORC ubiquitin ligase 1 |
decreases expression |
ISO |
Gold results in decreased expression of OBI1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:81,269,413...81,308,734
Ensembl chr15:81,269,416...81,308,734
|
|
G |
Odr4 |
odr-4 GPCR localization factor homolog |
decreases expression |
ISO |
Gold results in decreased expression of ODR4 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:62,369,109...62,424,287
Ensembl chr13:62,394,608...62,424,209
|
|
G |
Ogdh |
oxoglutarate dehydrogenase |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of OGDH mRNA |
CTD |
PMID:28433809 |
|
NCBI chr14:81,150,021...81,217,479
Ensembl chr14:81,150,091...81,217,479
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of OGG1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Orc4 |
origin recognition complex, subunit 4 |
decreases expression |
ISO |
Gold results in decreased expression of ORC4 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:33,290,844...33,334,022
Ensembl chr 3:33,294,355...33,333,824
|
|
G |
Os9 |
OS9, endoplasmic reticulum lectin |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of OS9 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 7:62,915,498...62,957,591
Ensembl chr 7:62,915,515...62,943,745
|
|
G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
increases expression |
ISO |
Gold results in increased expression of OSGIN1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
|
|
G |
P4hb |
prolyl 4-hydroxylase subunit beta |
decreases expression |
ISO |
Gold analog results in decreased expression of P4HB protein |
CTD |
PMID:24780912 |
|
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions decreases expression |
ISO |
Organogold Compounds promotes the reaction [Gold binds to PARP1 protein] Gold analog results in decreased expression of PARP1 mRNA |
CTD |
PMID:21370912 PMID:36057382 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcbp1 |
poly(rC) binding protein 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of PCBP1 protein |
CTD |
PMID:24780912 |
|
NCBI chr 4:118,972,698...118,974,705
Ensembl chr 4:118,972,661...118,976,500
|
|
G |
Pcca |
propionyl-CoA carboxylase subunit alpha |
decreases expression |
ISO |
Gold analog results in decreased expression of PCCA mRNA |
CTD |
PMID:36057382 |
|
NCBI chr15:99,627,955...99,969,555
Ensembl chr15:99,627,982...99,968,266
|
|
G |
Pcgf5 |
polycomb group ring finger 5 |
decreases expression |
ISO |
Gold results in decreased expression of PCGF5 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:234,063,854...234,180,022
Ensembl chr 1:234,063,892...234,175,315
|
|
G |
Pcgf6 |
polycomb group ring finger 6 |
decreases expression |
ISO |
Gold results in decreased expression of PCGF6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:245,925,354...245,944,964
Ensembl chr 1:245,925,360...245,944,914
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
ISO |
Gold analog results in decreased expression of PCNA mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pde4b |
phosphodiesterase 4B |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of PDE4B mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696
|
|
G |
Per3 |
period circadian regulator 3 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of PER3 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:161,460,228...161,495,404
Ensembl chr 5:161,459,533...161,495,607
|
|
G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
decreases expression |
ISO |
Gold results in decreased expression of PIGA mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:30,043,033...30,055,861
Ensembl chr X:30,042,343...30,055,804
|
|
G |
Pigf |
phosphatidylinositol glycan anchor biosynthesis, class F |
decreases expression |
ISO |
Gold results in decreased expression of PIGF mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:7,589,584...7,617,719
Ensembl chr 6:7,589,570...7,639,675
|
|
G |
Pigk |
phosphatidylinositol glycan anchor biosynthesis, class K |
decreases expression |
ISO |
Gold results in decreased expression of PIGK mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:241,630,021...241,715,493
Ensembl chr 2:241,630,053...241,716,134
|
|
G |
Pigy |
phosphatidylinositol glycan anchor biosynthesis, class Y |
decreases expression |
ISO |
Gold results in decreased expression of PIGY mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:20,689,621...20,691,863
Ensembl chr 8:20,689,502...20,692,585
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of PIK3R1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Pkm |
pyruvate kinase M1/2 |
decreases expression |
ISO |
Gold analog results in decreased expression of PKM protein |
CTD |
PMID:24780912 |
|
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
|
|
G |
Pla2g6 |
phospholipase A2 group VI |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of PLA2G6 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:110,851,378...110,891,557
Ensembl chr 7:110,851,378...110,891,114
|
|
G |
Plekhf2 |
pleckstrin homology and FYVE domain containing 2 |
decreases expression |
ISO |
Gold results in decreased expression of PLEKHF2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:24,091,077...24,106,758
Ensembl chr 5:24,090,688...24,106,601
|
|
G |
Plin3 |
perilipin 3 |
increases expression |
ISO |
Gold analog results in increased expression of PLIN3 protein |
CTD |
PMID:24780912 |
|
NCBI chr 9:1,111,178...1,123,057
Ensembl chr 9:1,102,366...1,123,147
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of PMAIP1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
|
|
G |
Polk |
DNA polymerase kappa |
decreases expression |
ISO |
Gold results in decreased expression of POLK mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:27,822,228...27,882,331
Ensembl chr 2:27,822,679...27,882,313
|
|
G |
Polr2k |
RNA polymerase II, I and III subunit K |
decreases expression |
ISO |
Gold results in decreased expression of POLR2K mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:67,347,118...67,359,466
Ensembl chr 7:67,356,113...67,357,668
|
|
G |
Popdc1 |
popeye domain cAMP effector 1 |
increases expression |
ISO |
Gold results in increased expression of POPDC1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr20:48,819,241...48,860,282
Ensembl chr20:48,822,308...48,857,472
|
|
G |
Popdc3 |
popeye domain cAMP effector 3 |
increases expression |
ISO |
Gold results in increased expression of POPDC3 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr20:48,772,397...48,800,677
Ensembl chr20:48,772,462...48,800,593
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of POR mRNA |
CTD |
PMID:28433809 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Ppp1cb |
protein phosphatase 1 catalytic subunit beta |
decreases expression |
ISO |
Gold results in decreased expression of PPP1CB mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:23,958,813...23,992,841
Ensembl chr 6:23,960,998...23,992,824
|
|
G |
Ppp2r1a |
protein phosphatase 2 scaffold subunit A alpha |
decreases expression |
ISO |
Gold analog results in decreased expression of PPP2R1A protein |
CTD |
PMID:24780912 |
|
NCBI chr 1:60,540,223...60,559,467
Ensembl chr 1:60,540,194...60,560,129
|
|
G |
Ppp2r5e |
protein phosphatase 2 regulatory subunit B', epsilon |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of PPP2R5E mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 6:94,168,846...94,317,872
Ensembl chr 6:94,168,846...94,317,872
|
|
G |
Prdx1 |
peroxiredoxin 1 |
decreases expression increases expression |
ISO |
Gold analog results in decreased expression of PRDX1 protein Gold analog results in increased expression of PRDX1 mRNA |
CTD |
PMID:24780912 PMID:36057382 |
|
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Prrc2a |
proline-rich coiled-coil 2A |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of PRRC2A mRNA |
CTD |
PMID:19695318 |
|
NCBI chr20:3,658,391...3,674,143
Ensembl chr20:3,658,695...3,674,130
|
|
G |
Psat1 |
phosphoserine aminotransferase 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of PSAT1 protein |
CTD |
PMID:24780912 |
|
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
|
|
G |
Psmd14 |
proteasome 26S subunit, non-ATPase 14 |
decreases expression |
ISO |
Gold results in decreased expression of PSMD14 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:46,254,338...46,347,076
Ensembl chr 3:46,254,330...46,347,076
|
|
G |
Ptbp2 |
polypyrimidine tract binding protein 2 |
decreases expression |
ISO |
Gold results in decreased expression of PTBP2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:207,812,659...207,874,019
Ensembl chr 2:207,812,920...207,873,506
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
increases expression |
ISO |
Gold results in increased expression of PTGR1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
|
|
G |
Ptgr2 |
prostaglandin reductase 2 |
decreases expression |
ISO |
Gold results in decreased expression of PTGR2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:103,931,367...103,963,113
Ensembl chr 6:103,931,409...103,963,111
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased expression of PTGS2 mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of PTGS2 mRNA Gold results in increased expression of PTGS2 mRNA |
CTD |
PMID:22155353 PMID:28433809 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
increases expression |
ISO |
Gold analog results in increased expression of PTPRC mRNA |
CTD |
PMID:36057382 |
|
NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692
|
|
G |
Pts |
6-pyruvoyl-tetrahydropterin synthase |
decreases expression |
ISO |
Gold results in decreased expression of PTS mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:50,870,838...50,877,869
Ensembl chr 8:50,870,841...50,877,869
|
|
G |
Pvr |
PVR cell adhesion molecule |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of PVR mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 1:79,561,294...79,576,700
Ensembl chr 1:79,546,879...79,576,715
|
|
G |
Rab11a |
RAB11a, member RAS oncogene family |
decreases expression |
ISO |
Gold results in decreased expression of RAB11A mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:65,223,698...65,246,461
Ensembl chr 8:65,222,949...65,246,525
|
|
G |
Rab18 |
RAB18, member RAS oncogene family |
decreases expression |
ISO |
Gold results in decreased expression of RAB18 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr17:54,944,099...54,976,093
Ensembl chr17:54,943,955...54,976,043
|
|
G |
Rabggtb |
Rab geranylgeranyltransferase subunit beta |
decreases expression |
ISO |
Gold results in decreased expression of RABGGTB mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:242,844,758...242,850,951
Ensembl chr 2:242,844,762...242,851,050
|
|
G |
Rad51 |
RAD51 recombinase |
decreases expression |
ISO |
Gold analog results in decreased expression of RAD51 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
|
|
G |
Rad51b |
RAD51 paralog B |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of RAD51B mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 6:98,096,525...98,640,988
Ensembl chr 6:98,098,868...98,640,979
|
|
G |
Rai14 |
retinoic acid induced 14 |
increases expression |
ISO |
Gold results in increased expression of RAI14 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 2:59,546,284...59,682,687
Ensembl chr 2:59,546,284...59,681,971
|
|
G |
Rb1cc1 |
RB1-inducible coiled-coil 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of RB1CC1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:13,161,648...13,225,560
Ensembl chr 5:13,161,648...13,225,560
|
|
G |
Rbm12 |
RNA binding motif protein 12 |
decreases expression |
ISO |
Gold results in decreased expression of RBM12 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:144,609,661...144,629,911
Ensembl chr 3:144,611,623...144,629,915
|
|
G |
Rbp1 |
retinol binding protein 1 |
increases expression |
ISO |
Gold results in increased expression of RBP1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 8:99,025,218...99,046,740
Ensembl chr 8:99,025,206...99,046,743
|
|
G |
Rc3h1 |
ring finger and CCCH-type domains 1 |
decreases expression |
ISO |
Gold results in decreased expression of RC3H1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:73,174,075...73,245,762
Ensembl chr13:73,173,946...73,238,839
|
|
G |
Rdx |
radixin |
decreases expression |
ISO |
Gold analog results in decreased expression of RDX mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:52,379,494...52,437,673
Ensembl chr 8:52,379,494...52,437,678
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of RELA protein] |
CTD |
PMID:27634460 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rfk |
riboflavin kinase |
decreases expression |
ISO |
Gold results in decreased expression of RFK mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:214,799,880...214,807,440
Ensembl chr 1:214,799,825...214,807,438 Ensembl chr X:214,799,825...214,807,438
|
|
G |
Rhou |
ras homolog family member U |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of RHOU mRNA |
CTD |
PMID:19695318 |
|
NCBI chr19:51,641,476...51,651,249
Ensembl chr19:51,641,227...51,650,552
|
|
G |
Rnf11 |
ring finger protein 11 |
decreases expression |
ISO |
Gold results in decreased expression of RNF11 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:124,212,433...124,243,125
Ensembl chr 5:124,212,445...124,234,750
|
|
G |
Rnf13 |
ring finger protein 13 |
decreases expression |
ISO |
Gold results in decreased expression of RNF13 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:141,927,887...142,061,801
Ensembl chr 2:141,927,909...142,061,801
|
|
G |
Rnf138 |
ring finger protein 138 |
decreases expression |
ISO |
Gold results in decreased expression of RNF138 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr18:12,291,557...12,315,931
Ensembl chr18:12,291,590...12,315,930
|
|
G |
Rnf149 |
ring finger protein 149 |
decreases expression |
ISO |
Gold results in decreased expression of RNF149 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:41,826,825...41,854,381
Ensembl chr 9:41,830,233...41,854,279
|
|
G |
Rnf2 |
ring finger protein 2 |
decreases expression |
ISO |
Gold results in decreased expression of RNF2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:63,553,964...63,584,047
Ensembl chr13:63,554,862...63,583,099
|
|
G |
Rnft1 |
ring finger protein, transmembrane 1 |
decreases expression |
ISO |
Gold results in decreased expression of RNFT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:71,310,052...71,322,507
Ensembl chr10:71,310,104...71,323,778
|
|
G |
Ro60 |
Ro60, Y RNA binding protein |
decreases expression |
ISO |
Gold results in decreased expression of RO60 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:55,499,514...55,520,504
Ensembl chr13:55,499,534...55,520,504
|
|
G |
Rp2 |
RP2 activator of ARL3 GTPase |
decreases expression |
ISO |
Gold results in decreased expression of RP2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:1,872,582...1,916,704
Ensembl chr X:1,873,306...1,916,688
|
|
G |
Rps27l |
ribosomal protein S27-like |
decreases expression |
ISO |
Gold results in decreased expression of RPS27L mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418 Ensembl chr12:67,562,483...67,567,418 Ensembl chr 2:67,562,483...67,567,418
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in decreased expression of RPS6KB1 protein |
CTD |
PMID:27470402 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
increases expression |
ISO |
Gold analog results in increased expression of HLA-DRB1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
|
|
G |
Rtn4 |
reticulon 4 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of RTN4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr14:103,450,074...103,497,687
Ensembl chr14:103,449,930...103,497,686
|
|
G |
Sar1b |
secretion associated, Ras related GTPase 1B |
decreases expression |
ISO |
Gold results in decreased expression of SAR1B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:36,024,415...36,054,069
Ensembl chr10:36,024,382...36,054,066
|
|
G |
Sarnp |
SAP domain containing ribonucleoprotein |
decreases expression |
ISO |
Gold results in decreased expression of SARNP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:1,251,096...1,305,335
Ensembl chr 7:1,251,098...1,305,332
|
|
G |
Scoc |
short coiled-coil protein |
decreases expression |
ISO |
Gold results in decreased expression of SCOC mRNA |
CTD |
PMID:25523186 |
|
NCBI chr19:24,659,651...24,689,237
Ensembl chr19:24,659,651...24,693,217
|
|
G |
Scp2 |
sterol carrier protein 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of SCP2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:122,806,949...122,881,259
Ensembl chr 5:122,776,549...122,881,287
|
|
G |
Sec23a |
Sec23 homolog A, COPII coat complex component |
decreases expression |
ISO |
Gold results in decreased expression of SEC23A mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:76,658,793...76,706,125
Ensembl chr 6:76,658,427...76,706,035
|
|
G |
Sec24a |
SEC24 homolog A, COPII coat complex component |
decreases expression |
ISO |
Gold results in decreased expression of SEC24A mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:35,946,901...36,024,353
Ensembl chr10:35,947,031...36,024,353
|
|
G |
Sel1l3 |
SEL1L family member 3 |
increases expression |
ISO |
Gold results in increased expression of SEL1L3 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr14:57,775,515...57,882,076
Ensembl chr14:57,775,501...57,882,644
|
|
G |
Selenot |
selenoprotein T |
decreases expression |
ISO |
Gold results in decreased expression of SELENOT mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:142,804,387...142,821,438
Ensembl chr 2:142,804,405...142,821,427
|
|
G |
Septin8 |
septin 8 |
decreases expression |
ISO |
Gold analog results in decreased expression of SEPTIN8 protein |
CTD |
PMID:24780912 |
|
NCBI chr10:37,684,649...37,713,704
Ensembl chr10:37,684,639...37,713,174
|
|
G |
Serp1 |
stress-associated endoplasmic reticulum protein 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of SERP1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 2:142,757,254...142,761,243
Ensembl chr 2:142,757,270...142,761,116
|
|
G |
Serpine1 |
serpin family E member 1 |
increases expression |
ISO |
Gold results in increased expression of SERPINE1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Serpinh1 |
serpin family H member 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of SERPINH1 protein |
CTD |
PMID:24780912 |
|
NCBI chr 1:153,643,500...153,650,853
Ensembl chr 1:153,643,510...153,650,801
|
|
G |
Sh3kbp1 |
SH3 domain-containing kinase-binding protein 1 |
increases expression |
ISO |
Gold results in increased expression of SH3KBP1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr X:34,877,862...35,223,013
Ensembl chr X:34,877,866...35,222,747
|
|
G |
Slc25a24 |
solute carrier family 25 member 24 |
decreases expression |
ISO |
Gold analog results in decreased expression of SLC25A24 protein |
CTD |
PMID:24780912 |
|
NCBI chr 2:196,761,076...196,799,236
Ensembl chr 2:196,761,274...196,799,231
|
|
G |
Slirp |
SRA stem-loop interacting RNA binding protein |
decreases expression |
ISO |
Gold results in decreased expression of SLIRP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:107,088,760...107,097,791
Ensembl chr 6:107,088,403...107,097,791
|
|
G |
Smarcad1 |
SNF2 related chromatin remodeling ATPase with DExD box 1 |
decreases expression |
ISO |
Gold results in decreased expression of SMARCAD1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:94,311,441...94,379,184
Ensembl chr 4:94,311,489...94,372,563
|
|
G |
Smc4 |
structural maintenance of chromosomes 4 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of SMC4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 2:153,240,243...153,268,722
Ensembl chr 2:153,240,283...153,271,571
|
|
G |
Smc6 |
structural maintenance of chromosomes 6 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of SMC6 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 6:33,978,730...34,033,201
Ensembl chr 6:33,978,716...34,031,746
|
|
G |
Snrpb2 |
small nuclear ribonucleoprotein polypeptide B2 |
decreases expression |
ISO |
Gold results in decreased expression of SNRPB2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:130,399,239...130,408,821
Ensembl chr 3:130,399,248...130,408,812
|
|
G |
Snx6 |
sorting nexin 6 |
decreases expression |
ISO |
Gold results in decreased expression of SNX6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:72,230,950...72,274,157
Ensembl chr 6:72,229,870...72,315,911
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of SOD1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sp100 |
SP100 nuclear antigen |
decreases expression |
ISO |
Gold results in decreased expression of SP100 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:86,310,990...86,377,036
Ensembl chr 9:86,311,032...86,377,034
|
|
G |
Sp3 |
Sp3 transcription factor |
decreases expression |
ISO |
Gold results in decreased expression of SP3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:57,811,855...57,857,150
Ensembl chr 3:57,812,075...57,860,342
|
|
G |
Spast |
spastin |
decreases expression |
ISO |
Gold results in decreased expression of SPAST mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:21,055,349...21,106,586
Ensembl chr 6:21,055,349...21,107,954
|
|
G |
Spata2 |
spermatogenesis associated 2 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of SPATA2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:156,202,962...156,213,283
Ensembl chr 3:156,202,967...156,211,705
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of SREBF1 mRNA Gold analog results in decreased expression of SREBF1 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Srek1ip1 |
SREK1-interacting protein 1 |
decreases expression |
ISO |
Gold results in decreased expression of SREK1IP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:35,975,978...35,999,636
Ensembl chr 2:35,975,989...35,999,636 Ensembl chr 7:35,975,989...35,999,636
|
|
G |
Srp9 |
signal recognition particle 9 |
decreases expression |
ISO |
Gold results in decreased expression of SRP9 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:93,832,580...93,840,720
Ensembl chr13:93,832,580...93,840,720
|
|
G |
Srsf10 |
serine and arginine rich splicing factor 10 |
decreases expression |
ISO |
Gold results in decreased expression of SRSF10 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:148,088,759...148,102,964
Ensembl chr 5:148,088,823...148,101,768
|
|
G |
Srsf3 |
serine and arginine rich splicing factor 3 |
decreases expression |
ISO |
Gold results in decreased expression of SRSF3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr20:7,091,928...7,101,860
Ensembl chr20:7,091,910...7,101,078
|
|
G |
Srsf7 |
serine and arginine rich splicing factor 7 |
decreases expression |
ISO |
Gold results in decreased expression of SRSF7 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:14,811,775...14,818,968
Ensembl chr 6:14,811,808...14,818,965
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions increases expression |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased expression of STAT1 mRNA Gold results in increased expression of STAT1 mRNA |
CTD |
PMID:22155353 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
increases expression multiple interactions |
ISO |
Gold results in increased expression of STAT3 mRNA [Gold co-treated with Silicon Dioxide] results in increased expression of STAT3 mRNA |
CTD |
PMID:22155353 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stau2 |
staufen double-stranded RNA binding protein 2 |
decreases expression |
ISO |
Gold results in decreased expression of STAU2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:2,840,741...3,084,935
Ensembl chr 5:2,840,765...3,084,929
|
|
G |
Stbd1 |
starch binding domain 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of STBD1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr14:15,470,452...15,473,857
Ensembl chr14:15,469,582...15,477,443
|
|
G |
Steap1 |
STEAP family member 1 |
decreases expression |
ISO |
Gold results in decreased expression of STEAP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:28,276,972...28,287,484
Ensembl chr 4:28,276,909...28,287,479
|
|
G |
Stk26 |
serine/threonine kinase 26 |
decreases expression |
ISO |
Gold results in decreased expression of STK26 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:130,325,064...130,375,674
Ensembl chr X:130,310,885...130,374,291
|
|
G |
Sucla2 |
succinate-CoA ligase ADP-forming subunit beta |
decreases expression |
ISO |
Gold analog results in decreased expression of SUCLA2 mRNA; Gold results in decreased expression of SUCLA2 mRNA |
CTD |
PMID:25523186 PMID:36057382 |
|
NCBI chr15:48,752,356...48,805,495
Ensembl chr15:48,752,312...48,805,138
|
|
G |
Syt1 |
synaptotagmin 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of SYT1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:43,813,204...44,358,020
Ensembl chr 7:43,815,785...44,357,803
|
|
G |
Syvn1 |
synoviolin 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of SYVN1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 1:203,339,235...203,346,137
Ensembl chr 1:203,339,619...203,346,152
|
|
G |
Tacstd2 |
tumor-associated calcium signal transducer 2 |
increases expression |
ISO |
Gold results in increased expression of TACSTD2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 4:96,707,950...96,709,650
Ensembl chr 4:96,707,951...96,709,650
|
|
G |
Tada1 |
transcriptional adaptor 1 |
decreases expression |
ISO |
Gold results in decreased expression of TADA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:78,632,908...78,646,863
Ensembl chr13:78,632,866...78,647,504
|
|
G |
Taf9b |
TATA-box binding protein associated factor 9b |
decreases expression |
ISO |
Gold results in decreased expression of TAF9B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:71,289,290...71,300,142
Ensembl chr X:71,289,290...71,300,604
|
|
G |
Tagln |
transgelin |
decreases expression |
ISO |
Gold analog results in decreased expression of TAGLN mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
|
|
G |
Tbl1xr1 |
TBL1X/Y related 1 |
decreases expression |
ISO |
Gold results in decreased expression of TBL1XR1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:104,788,950...104,929,055
Ensembl chr 2:104,801,721...104,929,055
|
|
G |
Tcea1 |
transcription elongation factor A1 |
decreases expression |
ISO |
Gold results in decreased expression of TCEA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:14,631,454...14,668,769
Ensembl chr 5:14,631,454...14,668,745 Ensembl chr15:14,631,454...14,668,745
|
|
G |
Tdo2 |
tryptophan 2,3-dioxygenase |
decreases expression |
ISO |
Gold results in decreased expression of TDO2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
|
|
G |
Tex30 |
testis expressed 30 |
decreases expression |
ISO |
Gold results in decreased expression of TEX30 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:46,243,416...46,252,273
Ensembl chr 9:46,242,748...46,252,249
|
|
G |
Tfec |
transcription factor EC |
decreases expression |
ISO |
Gold results in decreased expression of TFEC mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:45,106,129...45,180,236
Ensembl chr 4:45,107,641...45,180,236
|
|
G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
increases expression |
ISO |
Gold results in increased expression of TFPI2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 4:31,981,786...31,986,707
Ensembl chr 4:31,982,178...31,986,600
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of TGFB1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Thap1 |
THAP domain containing 1 |
decreases expression |
ISO |
Gold results in decreased expression of THAP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:65,905,348...65,909,942
Ensembl chr16:65,904,230...65,909,942
|
|
G |
Tia1 |
TIA1 cytotoxic granule-associated RNA binding protein |
decreases expression |
ISO |
Gold results in decreased expression of TIA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:118,852,765...118,883,252
Ensembl chr 4:118,852,837...118,880,586
|
|
G |
Tkt |
transketolase |
decreases expression |
ISO |
Gold analog results in decreased expression of TKT protein |
CTD |
PMID:24780912 |
|
NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,723,762...5,748,698
|
|
G |
Tlk1 |
tousled-like kinase 1 |
increases expression |
ISO |
Gold results in increased expression of TLK1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 3:55,520,559...55,627,580
Ensembl chr 3:55,503,358...55,691,968
|
|
G |
Tlr2 |
toll-like receptor 2 |
increases expression multiple interactions |
ISO |
Gold results in increased expression of TLR2 mRNA Gold promotes the reaction [SAA1 protein binds to TLR2 protein] |
CTD |
PMID:29705079 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tm4sf1 |
transmembrane 4 L six family member 1 |
increases expression |
ISO |
Gold results in increased expression of TM4SF1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 2:141,456,950...141,466,146
Ensembl chr 2:141,453,310...141,466,146
|
|
G |
Tmed10 |
transmembrane p24 trafficking protein 10 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of TMED10 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 6:104,991,843...105,026,705
Ensembl chr 6:104,991,838...105,026,753
|
|
G |
Tnf |
tumor necrosis factor |
increases secretion multiple interactions |
ISO |
Gold results in increased secretion of TNF protein [Gold co-treated with Silicon Dioxide] results in increased secretion of TNF protein |
CTD |
PMID:22155353 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of TNFAIP3 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tnfaip8l1 |
TNF alpha induced protein 8 like 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of TNFAIP8L1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 9:988,587...999,342
Ensembl chr 9:988,594...1,002,254
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of TNFRSF10A mRNA |
CTD |
PMID:28433809 |
|
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of TNFRSF1A mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
decreases expression |
ISO |
Gold analog results in decreased expression of TNFSF10 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
ISO |
Gold analog results in increased expression of TRP53 mRNA |
CTD |
PMID:22486372 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tpt1 |
tumor protein, translationally-controlled 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of TPT1 protein |
CTD |
PMID:24780912 |
|
NCBI chr15:51,156,728...51,159,629
Ensembl chr15:51,146,154...51,159,625
|
|
G |
Trim23 |
tripartite motif-containing 23 |
decreases expression |
ISO |
Gold results in decreased expression of TRIM23 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:35,302,405...35,335,746
Ensembl chr 2:35,302,409...35,335,743
|
|
G |
Trmt13 |
tRNA methyltransferase 13 homolog |
decreases expression |
ISO |
Gold results in decreased expression of TRMT13 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:204,533,630...204,547,711
Ensembl chr 2:204,533,632...204,546,843
|
|
G |
Trub1 |
TruB pseudouridine synthase family member 1 |
decreases expression |
ISO |
Gold results in decreased expression of TRUB1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:256,513,418...256,554,549
Ensembl chr 1:256,515,562...256,552,814
|
|
G |
Tuba1a |
tubulin, alpha 1A |
decreases expression |
ISO |
Gold analog results in decreased expression of TUBA1A protein |
CTD |
PMID:24780912 |
|
NCBI chr 7:130,113,214...130,116,880
Ensembl chr 7:130,081,032...130,196,186
|
|
G |
Tubb5 |
tubulin, beta 5 class I |
decreases expression |
ISO |
Gold analog results in decreased expression of TUBB5 protein |
CTD |
PMID:24780912 |
|
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
|
|
G |
Tufm |
Tu translation elongation factor, mitochondrial |
multiple interactions |
ISO |
Gold analog results in decreased expression of and results in increased phosphorylation of TUFM protein |
CTD |
PMID:24780912 |
|
NCBI chr 1:181,073,788...181,077,395
Ensembl chr 1:181,073,788...181,077,395
|
|
G |
Txndc5 |
thioredoxin domain containing 5 |
multiple interactions |
ISO |
Gold analog results in decreased expression of and results in increased phosphorylation of TXNDC5 protein |
CTD |
PMID:24780912 |
|
NCBI chr17:26,289,880...26,318,025
Ensembl chr17:26,289,880...26,318,025
|
|
G |
Txnip |
thioredoxin interacting protein |
decreases expression |
ISO |
Gold analog results in decreased expression of TXNIP mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
decreases activity increases expression |
EXP ISO |
Gold results in decreased activity of TXNRD1 protein Gold results in increased expression of TXNRD1 mRNA |
CTD |
PMID:16510263 PMID:20851179 PMID:29705079 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of TXNRD2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
|
|
G |
Uap1l1 |
UDP-N-acetylglucosamine pyrophosphorylase 1 like 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of UAP1L1 protein |
CTD |
PMID:24780912 |
|
NCBI chr 3:8,172,335...8,180,505
Ensembl chr 3:8,173,216...8,180,443
|
|
G |
Uba2 |
ubiquitin-like modifier activating enzyme 2 |
decreases expression |
ISO |
Gold results in decreased expression of UBA2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:86,775,239...86,802,685
Ensembl chr 1:86,775,244...86,802,682
|
|
G |
Ube2g2 |
ubiquitin-conjugating enzyme E2G 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of UBE2G2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr20:10,983,734...11,005,468
Ensembl chr20:10,983,742...11,005,447
|
|
G |
Ube2h |
ubiquitin-conjugating enzyme E2H |
increases expression |
ISO |
Gold results in increased expression of UBE2H mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 4:58,834,674...58,930,156
Ensembl chr 4:58,834,674...58,930,156
|
|
G |
Ube2n |
ubiquitin-conjugating enzyme E2N |
decreases expression |
ISO |
Gold results in decreased expression of UBE2N mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:30,154,330...30,184,373
Ensembl chr 7:30,154,616...30,184,355
|
|
G |
Ube2w |
ubiquitin-conjugating enzyme E2W |
decreases expression |
ISO |
Gold results in decreased expression of UBE2W mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:2,690,742...2,754,491
Ensembl chr 5:2,690,763...2,814,965
|
|
G |
Ucp2 |
uncoupling protein 2 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of UCP2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
decreases expression |
ISO |
Gold analog results in decreased expression of UGT1A1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2a1 |
UDP glucuronosyltransferase family 2 member A1 |
decreases expression |
ISO |
Gold analog results in decreased expression of UGT2A1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr14:20,521,018...20,545,934
Ensembl chr14:20,517,951...20,545,531
|
|
G |
Uimc1 |
ubiquitin interaction motif containing 1 |
increases expression decreases expression |
ISO |
Gold results in increased expression of UIMC1 mRNA Gold results in decreased expression of UIMC1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr17:9,523,793...9,592,810
Ensembl chr17:9,527,794...9,592,799
|
|
G |
Upp2 |
uridine phosphorylase 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of UPP2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 3:43,273,048...43,317,417
Ensembl chr 3:43,273,048...43,317,417
|
|
G |
Usp1 |
ubiquitin specific peptidase 1 |
decreases expression |
ISO |
Gold results in decreased expression of USP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:113,587,564...113,598,934
Ensembl chr 5:113,587,564...113,598,932
|
|
G |
Usp15 |
ubiquitin specific peptidase 15 |
decreases expression |
ISO |
Gold results in decreased expression of USP15 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:58,756,714...58,848,778
Ensembl chr 7:58,756,872...58,848,721
|
|
G |
Usp16 |
ubiquitin specific peptidase 16 |
decreases expression |
ISO |
Gold results in decreased expression of USP16 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:26,681,359...26,711,313
Ensembl chr11:26,681,414...26,710,539
|
|
G |
Usp33 |
ubiquitin specific peptidase 33 |
decreases expression |
ISO |
Gold results in decreased expression of USP33 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:241,283,209...241,328,479
Ensembl chr 2:241,292,985...241,328,479
|
|
G |
Usp5 |
ubiquitin specific peptidase 5 |
decreases expression |
ISO |
Gold analog results in decreased expression of USP5 protein |
CTD |
PMID:24780912 |
|
NCBI chr 4:157,619,663...157,634,681
Ensembl chr 4:157,619,643...157,634,711
|
|
G |
Vcl |
vinculin |
decreases expression |
ISO |
Gold analog results in decreased expression of VCL protein |
CTD |
PMID:24780912 |
|
NCBI chr15:3,265,776...3,355,586
Ensembl chr15:3,265,815...3,355,606
|
|
G |
Vim |
vimentin |
increases degradation |
ISO |
Gold analog results in increased degradation of VIM protein |
CTD |
PMID:26551149 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Wbp4 |
WW domain binding protein 4 |
decreases expression |
ISO |
Gold results in decreased expression of WBP4 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:54,862,700...54,890,668
Ensembl chr15:54,862,843...54,890,647
|
|
G |
Wee1 |
WEE1 G2 checkpoint kinase |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of WEE1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
|
|
G |
Xpa |
XPA, DNA damage recognition and repair factor |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of XPA mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 5:60,431,673...60,475,726
Ensembl chr 5:60,431,673...60,475,726
|
|
G |
Xpc |
XPC complex subunit, DNA damage recognition and repair factor |
decreases expression |
ISO |
Gold analog results in decreased expression of XPC mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 4:123,993,670...124,020,922
Ensembl chr 4:123,993,666...124,021,010
|
|
G |
Xrcc5 |
X-ray repair cross complementing 5 |
decreases expression |
ISO |
Gold analog results in decreased expression of XRCC5 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 9:73,955,216...74,044,020
Ensembl chr 9:73,955,216...74,044,018
|
|
G |
Yod1 |
YOD1 deubiquitinase |
decreases expression |
ISO |
Gold results in decreased expression of YOD1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:42,175,047...42,181,661
Ensembl chr13:42,174,820...42,177,205
|
|
G |
Ywhag |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of YWHAG mRNA |
CTD |
PMID:19695318 |
|
NCBI chr12:20,744,500...20,772,828
Ensembl chr12:20,744,535...20,772,827
|
|
G |
Zbtb21 |
zinc finger and BTB domain containing 21 |
decreases expression |
ISO |
Gold results in decreased expression of ZBTB21 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:37,312,337...37,327,040
Ensembl chr11:37,312,378...37,326,996
|
|
G |
Zbtb41 |
zinc finger and BTB domain containing 41 |
decreases expression |
ISO |
Gold results in decreased expression of ZBTB41 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:51,042,948...51,065,768
Ensembl chr13:51,042,948...51,065,768
|
|
G |
Zc3h15 |
zinc finger CCCH-type containing 15 |
decreases expression |
ISO |
Gold results in decreased expression of ZC3H15 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:68,744,591...68,764,335
Ensembl chr 3:68,744,604...68,764,333
|
|
G |
Zcchc10 |
zinc finger CCHC-type containing 10 |
decreases expression |
ISO |
Gold results in decreased expression of ZCCHC10 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:37,470,628...37,481,027
|
|
G |
Zcchc9 |
zinc finger CCHC-type containing 9 |
decreases expression |
ISO |
Gold results in decreased expression of ZCCHC9 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:23,038,156...23,048,249
Ensembl chr 2:23,038,317...23,048,217
|
|
G |
Zcrb1 |
zinc finger CCHC-type and RNA binding motif containing 1 |
decreases expression |
ISO |
Gold results in decreased expression of ZCRB1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:124,525,227...124,538,564
Ensembl chr 7:124,524,870...124,571,261
|
|
G |
Zdhhc17 |
zinc finger DHHC-type palmitoyltransferase 17 |
decreases expression |
ISO |
Gold results in decreased expression of ZDHHC17 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:46,369,963...46,433,691
Ensembl chr 7:46,369,988...46,433,764
|
|
G |
Zdhhc20 |
zinc finger DHHC-type palmitoyltransferase 20 |
decreases expression |
ISO |
Gold results in decreased expression of ZDHHC20 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:31,980,057...32,039,006
Ensembl chr15:31,983,155...32,038,989
|
|
G |
Zfand1 |
zinc finger AN1-type containing 1 |
decreases expression |
ISO |
Gold results in decreased expression of ZFAND1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:91,444,497...91,457,540
Ensembl chr 2:91,444,508...91,453,246
|
|
G |
Zfand6 |
zinc finger AN1-type containing 6 |
decreases expression |
ISO |
Gold results in decreased expression of ZFAND6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:138,581,002...138,652,052
Ensembl chr 1:138,581,002...138,651,939
|
|
G |
Zfp277 |
zinc finger protein 277 |
decreases expression |
ISO |
Gold results in decreased expression of ZNF277 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:57,383,454...57,512,785
Ensembl chr 6:57,383,951...57,512,765
|
|
G |
Zfp422 |
zinc finger protein 422 |
decreases expression |
ISO |
Gold results in decreased expression of ZNF22 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:149,885,805...149,893,287
Ensembl chr 4:149,885,600...149,893,257
|
|
G |
Zfyve16 |
zinc finger FYVE-type containing 16 |
decreases expression |
ISO |
Gold results in decreased expression of ZFYVE16 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:23,713,018...23,757,576
Ensembl chr 2:23,713,766...23,756,990
|
|
G |
Zmpste24 |
zinc metallopeptidase STE24 |
decreases expression |
ISO |
Gold results in decreased expression of ZMPSTE24 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:134,627,218...134,660,360
Ensembl chr 5:134,627,229...134,660,110
|
|
G |
Zranb2 |
zinc finger RANBP2-type containing 2 |
decreases expression |
ISO |
Gold results in decreased expression of ZRANB2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:246,573,110...246,586,942
Ensembl chr 2:246,573,166...246,586,942
|
|
G |
Zup1 |
zinc finger containing ubiquitin peptidase 1 |
decreases expression |
ISO |
Gold results in decreased expression of ZUP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr20:30,785,226...30,815,377
Ensembl chr20:30,785,227...30,815,306
|
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:36343453 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
affects binding |
ISO |
Auranofin analog binds to ALB protein |
CTD |
PMID:16791640 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
multiple interactions increases response to substance |
ISO |
[BAX co-treated with BAK1] results in increased susceptibility to Auranofin; BAK1 mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein] BAK1 results in increased susceptibility to Auranofin |
CTD |
PMID:18789312 PMID:21172426 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases response to substance |
ISO |
[BAX co-treated with BAK1] results in increased susceptibility to Auranofin; BAX mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein] BAX results in increased susceptibility to Auranofin |
CTD |
PMID:18789312 PMID:21172426 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO |
BCL2 protein inhibits the reaction [Auranofin results in increased activity of CASP3 protein] |
CTD |
PMID:18789312 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO EXP |
Auranofin promotes the reaction [TNF protein results in increased activity of CASP3 protein]; Auranofin results in decreased expression of and results in increased cleavage of CASP3 protein; BCL2 protein inhibits the reaction [Auranofin results in increased activity of CASP3 protein] BAK1 mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein]; BAX mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein] |
CTD |
PMID:15159275 PMID:15191400 PMID:18789312 PMID:20542334 PMID:21699084 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
Auranofin results in decreased expression of and results in increased cleavage of CASP8 protein |
CTD |
PMID:20542334 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
Auranofin results in decreased expression of and results in increased cleavage of CASP9 protein |
CTD |
PMID:20542334 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
Auranofin results in increased expression of CDKN1A protein |
CTD |
PMID:20542334 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cebpe |
CCAAT/enhancer binding protein epsilon |
multiple interactions |
ISO |
[Auranofin co-treated with Tretinoin] results in increased expression of CEBPE protein |
CTD |
PMID:15159275 |
|
NCBI chr15:28,169,711...28,171,471
Ensembl chr15:28,169,704...28,171,814
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
multiple interactions |
ISO |
Auranofin inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CHUK protein]; Auranofin inhibits the reaction [Lipopolysaccharides results in increased activity of CHUK protein] Auranofin inhibits the reaction [TNF protein results in increased activity of CHUK protein] |
CTD |
PMID:10820281 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Dio1 |
iodothyronine deiodinase 1 |
decreases activity |
ISO |
Auranofin results in decreased activity of DIO1 protein |
CTD |
PMID:34662569 |
|
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased expression of and results in increased secretion of EGF protein] |
CTD |
PMID:36343453 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions increases expression |
ISO |
[Peptidoglycan co-treated with Lipopolysaccharides] promotes the reaction [Auranofin results in increased expression of GPX1 protein]; Auranofin promotes the reaction [[Lipopolysaccharides co-treated with Peptidoglycan] results in increased expression of GPX1 protein] |
CTD |
PMID:21355852 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased activity of GSR protein] |
CTD |
PMID:36343453 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
Auranofin results in increased expression of HMOX1 mRNA Auranofin results in increased expression of HMOX1 mRNA; Auranofin results in increased expression of HMOX1 protein |
CTD |
PMID:22008538 PMID:23942037 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Auranofin inhibits the reaction [IL1B protein affects the localization of RELA protein]; Auranofin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; Auranofin inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] |
CTD |
PMID:10594346 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
[Auranofin co-treated with IL6 protein] results in decreased phosphorylation of IL6ST protein; [Auranofin co-treated with IL6 protein] results in decreased phosphorylation of JAK2 protein; [Auranofin co-treated with IL6 protein] results in decreased phosphorylation of STAT3 protein |
CTD |
PMID:20542334 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
multiple interactions |
ISO |
[Auranofin co-treated with IL6 protein] results in decreased phosphorylation of IL6ST protein |
CTD |
PMID:20542334 |
|
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [lipopolysaccharide A results in increased degradation of IRAK1 protein] |
CTD |
PMID:17034761 |
|
NCBI chr X:151,768,621...151,778,521
Ensembl chr X:151,768,777...151,778,521
|
|
G |
Irf3 |
interferon regulatory factor 3 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [lipopolysaccharide A results in increased activity of IRF3 protein]; Auranofin inhibits the reaction [lipopolysaccharide A results in increased phosphorylation of IRF3 protein]; Auranofin inhibits the reaction [TBK1 protein results in increased activity of IRF3 protein]; Auranofin inhibits the reaction [TICAM1 protein results in increased activity of IRF3 protein] |
CTD |
PMID:17034761 |
|
NCBI chr 1:95,479,966...95,484,926
Ensembl chr 1:95,479,821...95,484,935
|
|
G |
Itgam |
integrin subunit alpha M |
multiple interactions |
ISO |
[Auranofin co-treated with Tretinoin] results in increased expression of ITGAM protein |
CTD |
PMID:15159275 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Jak2 |
Janus kinase 2 |
multiple interactions |
ISO |
[Auranofin co-treated with IL6 protein] results in decreased phosphorylation of JAK2 protein |
CTD |
PMID:20542334 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:36343453 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:36343453 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:36343453 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
multiple interactions decreases expression |
ISO |
[Auranofin co-treated with SN50 peptide] results in decreased expression of MCL1 protein Auranofin results in decreased expression of MCL1 protein |
CTD |
PMID:20542334 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased expression of NFE2L2 protein] |
CTD |
PMID:36343453 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
Auranofin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein] |
CTD |
PMID:10820281 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfkbib |
NFKB inhibitor beta |
multiple interactions |
ISO |
Auranofin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIB protein] |
CTD |
PMID:10820281 |
|
NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:84,046,295...84,053,862
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
decreases activity increases cleavage |
ISO |
Auranofin results in decreased activity of PARP1 protein Auranofin results in increased cleavage of PARP1 protein |
CTD |
PMID:15159275 PMID:21370912 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Ppif |
peptidylprolyl isomerase F |
increases oxidation multiple interactions |
ISO EXP |
Auranofin results in increased oxidation of PPIF protein Auranofin inhibits the reaction [[NADP co-treated with TXNRD1 protein] results in increased activity of PPIF protein]; Cyclosporine promotes the reaction [Auranofin results in increased oxidation of PPIF protein] |
CTD |
PMID:26975474 |
|
NCBI chr16:1,257,197...1,263,919
Ensembl chr16:1,257,106...1,263,913
|
|
G |
Prdx3 |
peroxiredoxin 3 |
increases oxidation multiple interactions |
ISO EXP |
Auranofin results in increased oxidation of PRDX3 protein Cyclosporine promotes the reaction [Auranofin results in increased oxidation of PRDX3 protein] Auranofin promotes the reaction [[Lipopolysaccharides co-treated with Peptidoglycan] results in increased expression of PRDX3 protein] |
CTD |
PMID:18789312 PMID:21355852 PMID:26975474 |
|
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[lipopolysaccharide A co-treated with Auranofin] results in decreased expression of PTGS2 protein Auranofin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; Auranofin inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] |
CTD |
PMID:10594346 PMID:17034761 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases phosphorylation |
ISO |
Auranofin results in decreased phosphorylation of RB1 protein |
CTD |
PMID:20542334 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rbms3 |
RNA binding motif, single stranded interacting protein 3 |
affects response to substance |
ISO |
RBMS3 protein affects the susceptibility to Auranofin |
CTD |
PMID:36414028 |
|
NCBI chr 8:116,305,227...117,625,730
Ensembl chr 8:116,309,882...117,625,423
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Auranofin inhibits the reaction [IL1B protein affects the localization of RELA protein]; Auranofin promotes the reaction [arsenite results in increased phosphorylation of RELA protein] |
CTD |
PMID:10594346 PMID:36343453 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
increases response to substance |
ISO |
HLA-DQA1 gene polymorphism results in increased susceptibility to Auranofin |
CTD |
PMID:11436868 |
|
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
increases response to substance |
ISO |
HLA-DRB1 gene polymorphism results in increased susceptibility to Auranofin |
CTD |
PMID:11436868 |
|
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
decreases expression multiple interactions |
ISO |
Auranofin results in decreased expression of STAT3 protein modified form [Auranofin co-treated with IL6 protein] results in decreased phosphorylation of STAT3 protein |
CTD |
PMID:20542334 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tbk1 |
TANK-binding kinase 1 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [TBK1 protein results in increased activity of IRF3 protein] |
CTD |
PMID:17034761 |
|
NCBI chr 7:57,077,830...57,110,868
Ensembl chr 7:57,077,830...57,110,892
|
|
G |
Tgfa |
transforming growth factor alpha |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased expression of and results in increased secretion of TGFA protein] |
CTD |
PMID:36343453 |
|
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
|
|
G |
Ticam1 |
TIR domain containing adaptor molecule 1 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [TICAM1 protein results in increased activity of IRF3 protein] |
CTD |
PMID:17034761 |
|
NCBI chr 9:1,102,559...1,111,023
Ensembl chr 9:1,102,366...1,123,147
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [lipopolysaccharide A promotes the reaction [TLR4 protein binds to TLR4 protein]] |
CTD |
PMID:17034761 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Auranofin inhibits the reaction [TNF protein results in increased activity of CHUK protein]; Auranofin promotes the reaction [TNF protein results in increased activity of CASP3 protein] Auranofin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] |
CTD |
PMID:10820281 PMID:18789312 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Txn1 |
thioredoxin 1 |
increases oxidation multiple interactions |
ISO |
Auranofin results in increased oxidation of TXN protein Auranofin inhibits the reaction [arsenite results in increased expression of TXN protein] |
CTD |
PMID:26975474 PMID:36343453 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Txn2 |
thioredoxin 2 |
increases oxidation multiple interactions |
ISO EXP |
Auranofin results in increased oxidation of TXN2 protein Cyclosporine promotes the reaction [Auranofin results in increased oxidation of TXN2 protein] |
CTD |
PMID:26975474 |
|
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
multiple interactions decreases activity increases oxidation increases expression |
ISO EXP |
Auranofin inhibits the reaction [arsenite results in increased expression of and results in increased activity of TXNRD1 protein]; Auranofin inhibits the reaction [Sodium Selenite results in increased activity of TXNRD1 protein]; Auranofin promotes the reaction [Sodium Selenite results in increased expression of TXNRD1 mRNA]; potassium tellurate(IV) promotes the reaction [Auranofin results in increased oxidation of TXNRD1 protein]; Sodium Selenite promotes the reaction [Auranofin results in increased oxidation of TXNRD1 protein] Auranofin inhibits the reaction [[NADP co-treated with TXNRD1 protein] results in increased activity of PPIF protein]; Auranofin inhibits the reaction [[TXNRD1 protein co-treated with NADP] results in increased abundance of Superoxides] Auranofin results in decreased activity of TXNRD1 protein Auranofin results in increased expression of TXNRD1 mRNA |
CTD |
PMID:16510263 PMID:18405881 PMID:18789312 PMID:19486940 PMID:20457604 PMID:21172426 PMID:26975474 PMID:36343453 More...
|
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
multiple interactions decreases activity |
ISO EXP |
Auranofin inhibits the reaction [Sodium Selenite results in increased activity of TXNRD2 protein]; Auranofin promotes the reaction [Sodium Selenite results in decreased expression of TXNRD2 mRNA] Auranofin results in decreased activity of TXNRD2 protein |
CTD |
PMID:15458826 PMID:19486940 PMID:21172426 PMID:21355852 |
|
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
|
|
|
G |
Tnf |
tumor necrosis factor |
decreases secretion |
EXP |
Topical GNP decreases secretion of Tnf protein in aqeous humor |
RGD |
PMID:23150627 |
RGD:7815044 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of AASS mRNA Gold analog results in decreased expression of AASS mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression |
ISO |
Gold analog results in increased expression of ABCB1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABCB4 mRNA Gold analog results in decreased expression of ABCB4 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABCC1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression |
ISO |
Gold analog results in increased expression of ABCC2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABL1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
decreases expression |
ISO |
Gold analog results in decreased expression of ACAA1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
decreases expression |
ISO |
Gold analog results in decreased expression of ACACA mRNA |
CTD |
PMID:36057382 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acad11 |
acyl-CoA dehydrogenase family, member 11 |
decreases expression |
ISO |
Gold analog results in decreased expression of ACAD11 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:104,681,346...104,746,559
Ensembl chr 8:104,681,396...104,746,560
|
|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
decreases expression |
ISO |
Gold analog results in decreased expression of ACADM mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
|
|
G |
Acads |
acyl-CoA dehydrogenase short chain |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ACADS mRNA |
CTD |
PMID:28433809 |
|
NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898
|
|
G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ACADVL mRNA |
CTD |
PMID:28433809 |
|
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
|
|
G |
Aco1 |
aconitase 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of ACO1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
|
|
G |
Aco2 |
aconitase 2 |
decreases expression multiple interactions |
ISO |
Gold analog results in decreased expression of ACO2 protein [Polyethyleneimine binds to Gold] which results in increased expression of ACO2 mRNA |
CTD |
PMID:24780912 PMID:28433809 |
|
NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ACOX1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Acox2 |
acyl-CoA oxidase 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of ACOX2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160
|
|
G |
Acp1 |
acid phosphatase 1 |
decreases expression |
ISO |
Gold results in decreased expression of ACP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:47,506,380...47,522,021
Ensembl chr 6:47,506,380...47,522,021
|
|
G |
Acvr1c |
activin A receptor type 1C |
decreases expression |
ISO |
Gold results in decreased expression of ACVR1C mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:42,815,490...42,892,423
Ensembl chr 3:42,822,610...42,892,327
|
|
G |
Adam28 |
ADAM metallopeptidase domain 28 |
increases expression |
ISO |
Gold results in increased expression of ADAM28 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr15:43,774,463...43,840,726
Ensembl chr15:42,944,467...43,840,672
|
|
G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
decreases expression |
ISO |
Gold results in decreased expression of ADH5 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:226,975,184...226,987,591
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Adipor2 |
adiponectin receptor 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ADIPOR2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Adra1b |
adrenoceptor alpha 1B |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of ADRA1B mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:28,255,025...28,373,418
Ensembl chr10:28,255,025...28,312,919
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of ADRB2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Ahsg |
alpha-2-HS-glycoprotein |
decreases expression |
ISO |
Gold analog results in decreased expression of AHSG mRNA |
CTD |
PMID:36057382 |
|
NCBI chr11:78,121,388...78,127,998
Ensembl chr11:78,117,918...78,145,999
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
increases expression |
ISO |
Gold results in increased expression of AIFM1 protein |
CTD |
PMID:25462594 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
decreases expression |
ISO |
Gold results in decreased expression of AIMP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:221,151,907...221,175,458
Ensembl chr 2:221,151,904...221,175,728
|
|
G |
Ak3 |
adenylate kinase 3 |
decreases expression |
ISO |
Gold results in decreased expression of AK3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
|
|
G |
Akap13 |
A-kinase anchoring protein 13 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of AKAP13 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:129,313,183...129,619,647
Ensembl chr 1:129,314,402...129,619,646
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
Gold results in increased expression of AKR1B10 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Gold results in increased expression of AKR1C2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
increases expression |
ISO |
Gold results in increased expression of AKR1C3 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:27470402 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
multiple interactions increases expression |
ISO |
ALB protein results in increased uptake of [Polyethylene Glycols binds to Gold]; ALB protein results in increased uptake of [Polyethyleneimine binds to Gold]; ALB protein results in increased uptake of [Thioctic Acid binds to Gold] Gold analog results in increased expression of ALB mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Anxa5 |
annexin A5 |
increases expression |
ISO |
Gold analog results in increased expression of ANXA5 protein |
CTD |
PMID:24780912 |
|
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of APAF1 mRNA; [Quercetin analog co-treated with Gold analog] results in increased expression of APAF1 protein Gold analog results in decreased expression of APAF1 mRNA |
CTD |
PMID:27470402 PMID:28433809 PMID:36057382 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of APEX1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Apoa4 |
apolipoprotein A4 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of APOA4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Aprt |
adenine phosphoribosyl transferase |
decreases expression |
ISO |
Gold analog results in decreased expression of APRT protein |
CTD |
PMID:24780912 |
|
NCBI chr19:50,626,201...50,628,491
Ensembl chr19:50,626,202...50,628,431
|
|
G |
Aqp4 |
aquaporin 4 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of AQP4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Arl1 |
ARF like GTPase 1 |
decreases expression |
ISO |
Gold results in decreased expression of ARL1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:23,120,004...23,131,173
Ensembl chr 7:23,119,589...23,131,898
|
|
G |
Arl5b |
ARF like GTPase 5B |
decreases expression |
ISO |
Gold results in decreased expression of ARL5B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr17:77,955,864...77,979,895
Ensembl chr17:77,955,818...77,979,854
|
|
G |
Arsg |
arylsulfatase G |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ARSG mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:94,412,261...94,551,224
Ensembl chr10:94,447,399...94,542,941
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of ASAH1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
|
|
G |
Atf1 |
activating transcription factor 1 |
decreases expression |
ISO |
Gold results in decreased expression of ATF1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:131,361,962...131,404,677
Ensembl chr 7:131,362,450...131,404,670
|
|
G |
Atf4 |
activating transcription factor 4 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ATF4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
increases cleavage |
ISO |
Gold analog results in increased cleavage of ATF6 protein |
CTD |
PMID:26551149 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atic |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
decreases expression |
ISO |
Gold analog results in decreased expression of ATIC protein |
CTD |
PMID:24780912 |
|
NCBI chr 9:73,164,846...73,184,897
Ensembl chr 9:73,164,846...73,184,889
|
|
G |
Atl2 |
atlastin GTPase 2 |
decreases expression |
ISO |
Gold results in decreased expression of ATL2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:15,139,071...15,180,421
Ensembl chr 6:15,139,044...15,180,421
|
|
G |
Atm |
ATM serine/threonine kinase |
decreases expression |
ISO |
Gold analog results in decreased expression of ATM mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp2b1 |
ATPase plasma membrane Ca2+ transporting 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ATP2B1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:33,735,595...33,845,226
Ensembl chr 7:33,735,871...33,843,295
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
multiple interactions |
ISO |
Gold analog results in increased expression of and results in decreased phosphorylation of ATP5F1B protein |
CTD |
PMID:24780912 |
|
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
|
|
G |
Atp6v1g2 |
ATPase H+ transporting V1 subunit G2 |
decreases expression |
ISO |
Gold analog results in decreased expression of ATP6V1G2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr20:3,587,681...3,591,309
Ensembl chr20:3,587,686...3,590,481
|
|
G |
Atr |
ATR serine/threonine kinase |
decreases expression |
ISO |
Gold analog results in decreased expression of ATR mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
|
|
G |
Bace1 |
beta-secretase 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of BACE1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in increased expression of BAD protein |
CTD |
PMID:27470402 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Baiap2 |
BAR/IMD domain containing adaptor protein 2 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of BAIAP2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:105,223,065...105,290,130
Ensembl chr10:105,223,090...105,290,134
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression |
ISO |
Gold results in increased expression of BAK1 mRNA |
CTD |
PMID:22178767 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO EXP |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which affects the localization of BAX protein; [Gold analog co-treated with Platinum] results in increased expression of BAX mRNA; [Polyethyleneimine binds to Gold] which results in decreased expression of BAX mRNA; [Quercetin analog co-treated with Gold analog] results in increased expression of BAX protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of BAX protein Gold results in increased expression of BAX mRNA |
CTD |
PMID:21621595 PMID:22178767 PMID:25846798 PMID:27470402 PMID:27836789 PMID:28433809 More...
|
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcas2 |
BCAS2, pre-mRNA processing factor |
decreases expression |
ISO |
Gold results in decreased expression of BCAS2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:190,692,503...190,700,386
Ensembl chr 2:190,692,461...190,700,389
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO EXP |
[Gold analog co-treated with Platinum] results in decreased expression of BCL2 mRNA; [Quercetin analog co-treated with Gold analog] results in decreased expression of BCL2 protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in decreased expression of BCL2 protein |
CTD |
PMID:25846798 PMID:27470402 PMID:27836789 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of BCL2L1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
decreases expression |
ISO |
Gold analog results in decreased expression of BCL2L11 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
decreases expression |
ISO |
Gold results in decreased expression of BIRC2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
decreases expression |
ISO |
Gold analog results in decreased expression of BIRC3 mRNA; Gold results in decreased expression of BIRC3 mRNA |
CTD |
PMID:25523186 PMID:36057382 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Bmal1 |
basic helix-loop-helix ARNT like 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of BMAL1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
|
|
G |
Bmi1 |
BMI1 proto-oncogene, polycomb ring finger |
decreases expression |
ISO |
Gold results in decreased expression of BMI1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr17:81,332,175...81,341,625
Ensembl chr17:81,332,214...81,388,690
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of BRCA1 mRNA Gold analog results in decreased expression of BRCA1 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of BRCA2 mRNA Gold analog results in decreased expression of BRCA2 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
C1d |
C1D nuclear receptor corepressor |
decreases expression |
ISO |
Gold results in decreased expression of C1D mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:91,660,951...91,673,177
Ensembl chr14:91,660,989...91,672,852
|
|
G |
C3 |
complement C3 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of C3 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C8h11orf54 |
similar to human chromosome 11 open reading frame 54 |
decreases expression |
ISO |
Gold results in decreased expression of C11ORF54 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473
|
|
G |
C9 |
complement C9 |
decreases expression |
ISO |
Gold analog results in decreased expression of C9 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338
|
|
G |
Capza2 |
capping actin protein of muscle Z-line subunit alpha 2 |
decreases expression |
ISO |
Gold results in decreased expression of CAPZA2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:45,978,142...46,014,032
Ensembl chr 4:45,977,807...46,013,864
|
|
G |
Car13 |
carbonic anhydrase 13 |
decreases expression |
ISO |
Gold results in decreased expression of CA13 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:86,928,401...86,959,525
Ensembl chr 2:86,928,383...86,959,525
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of CASP1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity increases cleavage increases expression |
ISO EXP |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which results in increased activity of CASP3 protein; [Gold analog co-treated with Platinum] results in increased activity of CASP3 protein; [Gold analog co-treated with Platinum] results in increased expression of CASP3 mRNA; [Polyethyleneimine binds to Gold] which results in increased expression of CASP3 mRNA; [Quercetin analog co-treated with Gold analog] results in increased cleavage of CASP3 protein; [Quercetin analog co-treated with Gold analog] results in increased expression of and results in increased activity of CASP3 protein; Dexamethasone promotes the reaction [Gold results in increased activity of CASP3 protein]; Etoposide promotes the reaction [Gold results in increased activity of CASP3 protein] [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of CASP3 protein Gold analog results in increased cleavage of CASP3 protein Gold results in increased expression of CASP3 mRNA |
CTD |
PMID:19760634 PMID:21621595 PMID:22178767 PMID:25846798 PMID:26551149 PMID:27470402 PMID:27836789 PMID:28433809 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
increases cleavage |
ISO |
Gold analog results in increased cleavage of CASP4 protein |
CTD |
PMID:26551149 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp7 |
caspase 7 |
increases cleavage |
ISO |
Gold analog results in increased cleavage of CASP7 protein |
CTD |
PMID:26551149 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
increases expression decreases expression |
ISO |
Gold results in increased expression of CASP8 mRNA Gold analog results in decreased expression of CASP8 mRNA |
CTD |
PMID:22178767 PMID:36057382 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases cleavage |
ISO EXP |
[Gold analog co-treated with Platinum] results in increased activity of CASP9 protein; [Gold analog co-treated with Platinum] results in increased expression of CASP9 mRNA [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of CASP9 protein Gold analog results in increased cleavage of CASP9 protein |
CTD |
PMID:25846798 PMID:26551149 PMID:27836789 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
[Gold binds to NKCT1 protein, Naja kaouthia] inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein] |
CTD |
PMID:27836789 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbx3 |
chromobox 3 |
decreases expression |
ISO |
Gold results in decreased expression of CBX3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:80,545,450...80,559,284
Ensembl chr 4:80,546,010...80,559,283 Ensembl chr 4:80,546,010...80,559,283
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL2 protein Gold results in increased secretion of CCL2 protein |
CTD |
PMID:22155353 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL5 protein Gold results in increased secretion of CCL5 protein |
CTD |
PMID:22155353 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL7 protein Gold results in increased secretion of CCL7 protein |
CTD |
PMID:22155353 |
|
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in decreased expression of CCND1 protein |
CTD |
PMID:27470402 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
decreases expression |
ISO |
Gold analog results in decreased expression of CCT5 protein |
CTD |
PMID:24780912 |
|
NCBI chr 2:82,591,750...82,602,903
Ensembl chr 2:82,590,630...82,602,930
|
|
G |
Cd19 |
CD19 molecule |
increases expression |
ISO |
Gold analog results in increased expression of CD19 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:180,987,286...180,993,920
Ensembl chr 1:180,987,286...180,993,975
|
|
G |
Cd36 |
CD36 molecule |
decreases expression |
ISO |
Gold analog results in decreased expression of CD36 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd40 |
CD40 molecule |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CD40 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd86 |
CD86 molecule |
decreases expression |
ISO |
Gold analog results in decreased expression of CD86 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cda |
cytidine deaminase |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CDA mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:150,556,615...150,583,231
Ensembl chr 5:150,556,615...150,583,231
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression increases expression |
ISO |
Gold results in decreased expression of CDK1 mRNA Gold results in increased expression of CDK1 mRNA |
CTD |
PMID:25523186 PMID:29705079 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk7 |
cyclin-dependent kinase 7 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CDK7 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 2:31,840,558...31,865,422
Ensembl chr 2:31,840,558...31,865,383
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
ISO |
[Gold binds to Dimethyldithiocarbamate] which results in increased expression of CDKN1B protein |
CTD |
PMID:17079469 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2aip |
CDKN2A interacting protein |
decreases expression |
ISO |
Gold results in decreased expression of CDKN2AIP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:44,536,147...44,546,216
Ensembl chr16:44,536,234...44,540,033
|
|
G |
Cgrrf1 |
cell growth regulator with ring finger domain 1 |
decreases expression |
ISO |
Gold results in decreased expression of CGRRF1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:20,088,564...20,109,042
Ensembl chr15:20,088,571...20,109,037
|
|
G |
Chek1 |
checkpoint kinase 1 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CHEK1 mRNA Gold analog results in decreased expression of CHEK1 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chek2 |
checkpoint kinase 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of CHEK2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Chordc1 |
cysteine and histidine rich domain containing 1 |
decreases expression |
ISO |
Gold results in decreased expression of CHORDC1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:15,374,471...15,399,162
|
|
G |
Cisd1 |
CDGSH iron sulfur domain 1 |
decreases expression |
ISO |
Gold results in decreased expression of CISD1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr20:17,255,302...17,268,688
Ensembl chr20:17,255,151...17,284,924
|
|
G |
Cldn12 |
claudin 12 |
decreases expression |
ISO |
Gold results in decreased expression of CLDN12 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:28,522,659...28,533,647
Ensembl chr 4:28,522,678...28,533,801
|
|
G |
Cnbp |
CCHC-type zinc finger, nucleic acid binding protein |
decreases expression |
ISO |
Gold results in decreased expression of CNBP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:120,302,768...120,311,694
Ensembl chr 4:120,302,771...120,311,637
|
|
G |
Cnot7 |
CCR4-NOT transcription complex, subunit 7 |
decreases expression |
ISO |
Gold results in decreased expression of CNOT7 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:51,775,416...51,794,581
Ensembl chr16:51,775,412...51,794,576
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
increases expression |
ISO |
Gold analog results in increased expression of COL1A1 protein |
CTD |
PMID:24780912 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of COL1A2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of COL3A1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Commd8 |
COMM domain containing 8 |
decreases expression |
ISO |
Gold results in decreased expression of COMMD8 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:36,049,040...36,059,617
Ensembl chr14:36,049,004...36,059,617
|
|
G |
Cox11 |
cytochrome c oxidase copper chaperone COX11 |
decreases expression |
ISO |
Gold results in decreased expression of COX11 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:75,458,735...75,465,322
Ensembl chr10:75,458,749...75,465,322
|
|
G |
Cox17 |
cytochrome c oxidase copper chaperone COX17 |
decreases expression |
ISO |
Gold results in decreased expression of COX17 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:62,400,733...62,406,507
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CPT1A mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CPT2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Crot |
carnitine O-octanoyltransferase |
decreases expression |
ISO |
Gold analog results in decreased expression of CROT mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CSF2 protein Gold results in increased secretion of CSF2 protein |
CTD |
PMID:22155353 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csf3 |
colony stimulating factor 3 |
increases secretion multiple interactions |
ISO |
Gold results in increased secretion of CSF3 protein [Gold co-treated with Silicon Dioxide] results in increased secretion of CSF3 protein |
CTD |
PMID:22155353 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Ctcf |
CCCTC-binding factor |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CTCF mRNA |
CTD |
PMID:19695318 |
|
NCBI chr19:33,521,726...33,571,124
Ensembl chr19:33,529,319...33,571,123
|
|
G |
Cux1 |
cut-like homeobox 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CUX1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr12:20,107,062...20,425,868
Ensembl chr12:20,107,311...20,425,866 Ensembl chr 4:20,107,311...20,425,866
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases secretion multiple interactions |
ISO |
Gold results in increased secretion of CXCL10 protein [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL10 protein |
CTD |
PMID:22155353 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions increases secretion |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CXCL2 mRNA; [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL2 protein Gold results in increased secretion of CXCL2 protein |
CTD |
PMID:19695318 PMID:22155353 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CXCL1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which affects the localization of CYCS protein |
CTD |
PMID:21621595 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases activity decreases expression multiple interactions |
ISO |
Gold analog results in increased activity of CYP1A1 protein Gold analog results in decreased expression of CYP1A1 mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of CYP1A1 mRNA |
CTD |
PMID:20193702 PMID:28433809 PMID:36057382 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
increases expression |
ISO |
Gold results in increased expression of CYP24A1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CYP2D6 mRNA Gold analog results in decreased expression of CYP2D6 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
increases expression |
ISO |
Gold analog results in increased expression of CYP7A1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cyth1 |
cytohesin 1 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CYTH1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:103,402,727...103,485,826
Ensembl chr10:103,366,145...103,485,760
|
|
G |
Dab2 |
DAB adaptor protein 2 |
increases expression |
ISO |
Gold results in increased expression of DAB2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 2:55,514,692...55,567,476
Ensembl chr 2:55,514,700...55,567,476
|
|
G |
Dcp2 |
decapping mRNA 2 |
decreases expression |
ISO |
Gold results in decreased expression of DCP2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr18:36,750,732...36,787,067
Ensembl chr18:36,750,732...36,788,557
|
|
G |
Ddc |
dopa decarboxylase |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of DDC mRNA |
CTD |
PMID:19695318 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of DDIT3 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
multiple interactions |
ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of DDIT4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Defb1 |
defensin beta 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of DEFB1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
multiple interactions decreases expression |
ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of DHCR24 mRNA Gold analog results in decreased expression of DHCR24 mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of DHCR24 mRNA |
CTD |
PMID:19695318 PMID:28433809 PMID:36057382 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dld |
dihydrolipoamide dehydrogenase |
decreases expression |
ISO |
Gold analog results in decreased expression of DLD mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 6:47,904,153...47,924,814
Ensembl chr 6:47,903,914...47,924,795
|
|
G |
Dnah14 |
dynein axonemal heavy chain 14 |
decreases expression |
ISO |
Gold results in decreased expression of DNAH14 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:93,322,653...93,540,706
Ensembl chr13:93,322,711...93,538,646
|
|
G |
Dnaja3 |
DnaJ heat shock protein family (Hsp40) member A3 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of DNAJA3 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr10:10,854,732...10,880,171
Ensembl chr10:10,854,732...10,880,161
|
|
G |
Dnajb14 |
DnaJ heat shock protein family (Hsp40) member B14 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJB14 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:226,358,988...226,409,461
Ensembl chr 2:226,358,996...226,402,490
|
|
G |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJB6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:5,452,683...5,556,679
Ensembl chr 4:5,452,683...5,556,659
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJB9 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Dnajc10 |
DnaJ heat shock protein family (Hsp40) member C10 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJC10 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:65,232,031...65,272,732
Ensembl chr 3:65,232,697...65,272,719
|
|
G |
Dnajc19 |
DnaJ heat shock protein family (Hsp40) member C19 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJC19 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:116,923,272...116,945,312
Ensembl chr 2:116,923,272...116,945,264
|
|
G |
Dnajc21 |
DnaJ heat shock protein family (Hsp40) member C21 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJC21 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:59,419,507...59,446,746
Ensembl chr 2:59,419,510...59,446,752
|
|
G |
Dnajc5 |
DnaJ heat shock protein family (Hsp40) member C5 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of DNAJC5 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:168,621,905...168,656,570
Ensembl chr 3:168,621,969...168,655,935
|
|
G |
Dpysl4 |
dihydropyrimidinase-like 4 |
increases expression |
ISO |
Gold analog results in increased expression of DPYSL4 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:193,883,039...193,898,916
Ensembl chr 1:193,883,106...193,898,914
|
|
G |
Drd3 |
dopamine receptor D3 |
multiple interactions |
EXP |
Gold inhibits the reaction [3-N-methylspiperone binds to DRD3 protein] |
CTD |
PMID:10215675 |
|
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
|
|
G |
Drd4 |
dopamine receptor D4 |
multiple interactions |
EXP |
Gold inhibits the reaction [3-N-methylspiperone binds to DRD4 protein] |
CTD |
PMID:10215675 |
|
| |